AMPKA2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00418 | S366 | SIGNOR|ELM|iPTMNet|EPSD | EEF2K | AKtILRGtEEKCGsPQVRTLsGSRPPLLRPLsENSGDENMS |
| O00418 | S398 | SIGNOR|ELM|iPTMNet|EPSD|PSP | EEF2K | ENSGDENMSDVTFDsLPSsPsSATPHSQKLDHLHWPVFSDL |
| O00418 | S78 | SIGNOR|ELM|iPTMNet|EPSD | EEF2K | KYysNLtKsERysssGsPANsFHFKEAWKHAIQKAKHMPDP |
| O00763 | S222 | SIGNOR|ELM|iPTMNet|EPSD | ACACB ACC2 ACCB | EAYLTTGEAETRVPTMRPSMsGLHLVKRGREHKKLDLHRDF |
| O14920 | S177 | SIGNOR|EPSD|PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | SIGNOR|EPSD|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14929 | S190 | SIGNOR | HAT1 KAT1 | GFREYHERLQTFLMWFIETAsFIDVDDERWHYFLVFEKYNK |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O43524 | S399 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | NDGLTENLMDDLLDNITLPPsQPSPTGGLMQRSSsFPYTTK |
| O43524 | S413 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | NITLPPsQPSPTGGLMQRSSsFPYTTKGsGLGsPtssFNst |
| O43524 | S555 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | HHQHQTQGALGGSRALsNsVsNMGLSESSSLGSAKHQQQsP |
| O43524 | S588 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | AKHQQQsPVSQSMQTLSDSLsGSSLYSTSANLPVMGHEKFP |
| O43524 | S626 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | KFPSDLDLDMFNGSLECDMEsIIRSELMDADGLDFNFDsLI |
| O43524 | T179 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | NLSYADLITRAIESSPDKRLtLSQIYEWMVRCVPYFKDKGD |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60825 | S466 | SIGNOR|ELM|iPTMNet|EPSD | PFKFB2 | RDKPTNNFPKNQTPVRMRRNsFtPLsssNtIRRPRNYsVGs |
| O75128 | S1171 | Sugiyama | COBL KIAA0633 | SALLAAIRGHSGTCSLRKVAsSAsEELQSFRDAALSAQGSE |
| O75128 | S1174 | Sugiyama | COBL KIAA0633 | LAAIRGHSGTCSLRKVAsSAsEELQSFRDAALSAQGSESPL |
| O75151 | S655 | PSP | PHF2 CENP-35 KIAA0662 | FSFsFsNKKLLGSKALRPPtsPGVFGALQNFKEDKPKPVRD |
| O75385 | S317 | SIGNOR | ULK1 KIAA0722 | ssGSGSSSSSSSTSHLASPPsLGEMQQLQKTLAsPADTAGF |
| O75385 | S556 | SIGNOR | ULK1 KIAA0722 | PGssAPEHsPRTSGLGCRLHsAPNLSDLHVVRPKLPKPPTD |
| O75385 | S638 | SIGNOR | ULK1 KIAA0722 | PPILGsPtKAVPSFDFPKtPssQNLLALLARQGVVMTPPRN |
| O95278 | S25 | SIGNOR | EPM2A | FGVVVPPAVAGARPELLVVGsRPELGRWEPRGAVRLRPAGT |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04049 | S259 | SIGNOR | RAF1 RAF | tFNtssPSSEGSLSQRQRststPNVHMVsttLPVDSRMIED |
| P04049 | S621 | SIGNOR | RAF1 RAF | QILssIELLQHsLPKINRsAsEPsLHRAAHtEDINACtLtt |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S122 | SIGNOR | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FttMEKAGAHLQGGAKRVIIsAPsADAPMFVMGVNHEKYDN |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S15 | SIGNOR | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05091 | T356 | SIGNOR | ALDH2 ALDM | VERSVARAKSRVVGNPFDSKtEQGPQVDETQFKKILGYINT |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05549 | S219 | EPSD|PSP | TFAP2A AP2TF TFAP2 | NLFGGVVNPNEVFCSVPGRLsLLsstsKYKVTVAEVQRRLs |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06400 | S811 | SIGNOR | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07711 | S329 | Sugiyama | CTSL CTSL1 | GGyVKMAKDRRNHCGIAsAAsyPtV________________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07954 | S75 | SIGNOR | FH | DtFGELKVPNDKYYGAQTVRsTMNFKIGGVTERMPtPVIKA |
| P08151 | S102 | SIGNOR|EPSD|PSP | GLI1 GLI | ALsISPLSDASLDLQTVIRTsPSSLVAFINSRCTsPGGSYG |
| P08151 | S408 | SIGNOR|EPSD|PSP | GLI1 GLI | GPDAHVtKRHRGDGPLPRAPsISTVEPKREREGGPIREESR |
| P08151 | T1074 | SIGNOR|EPSD|PSP | GLI1 GLI | DEPQGLSPPPSHDQRGSsGHtPPPsGPPNMAVGNMsVLLRS |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T94 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSGtKAFM |
| P08559 | S295 | SIGNOR|PSP | PDHA1 PHE1A | SGKGPILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsKsD |
| P08559 | S314 | SIGNOR|PSP | PDHA1 PHE1A | MsDPGVsyRtREEIQEVRsKsDPIMLLKDRMVNSNLAsVEE |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09874 | S177 | EPSD|PSP | PARP1 ADPRT PPOL | WYHPGCFVKNREELGFRPEYsAsQLKGFsLLAtEDKEALKK |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10636 | S214 | SIGNOR | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P10636 | S396 | SIGNOR | MAPT MAPTL MTBT1 TAU | ARMVSKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPT |
| P10636 | S420 | SIGNOR | MAPT MAPTL MTBT1 TAU | sAKtLKNRPCLsPKHPTPGSsDPLIQPssPAVCPEPPssPK |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11532 | S3624 | Sugiyama | DMD | AKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEED |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11908 | S180 | SIGNOR | PRPS2 | AEWKNCIIVSPDAGGAKRVTsIADRLNVEFALIHKERKKAN |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13569 | S737 | SIGNOR | CFTR ABCC7 | TPLQMNGIEEDSDEPLERRLsLVPDSEQGEAILPRIsVIST |
| P13569 | S768 | SIGNOR | CFTR ABCC7 | ILPRIsVISTGPTLQARRRQsVLNLMTHSVNQGQNIHRKTT |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13807 | S8 | SIGNOR | GYS1 GYS | _____________MPLNRTLsMssLPGLEDWEDEFDLENAV |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S139 | Sugiyama | NELFE RD RDBP | DLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGAG |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P22460 | S559 | SIGNOR | KCNA5 | QGTQSQGPGLDRGVQRKVSGsRGSFCKAGGTLENADSARRG |
| P22460 | S592 | SIGNOR | KCNA5 | NADSARRGSCPLEKCNVKAKsNVDLRRSLYALCLDTSRETD |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P26358 | S714 | SIGNOR | DNMT1 AIM CXXC9 DNMT | MAMKEADDDEEVDDNIPEMPsPKKMHQGKKKKQNKNRIsWV |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P28562 | S334 | SIGNOR|EPSD|PSP | DUSP1 CL100 MKP1 PTPN10 VH1 | APHCSAEAGsPAMAVLDRGTsTTTVFNFPVSIPVHSTNSAL |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29474 | S1177 | SIGNOR | NOS3 | EDIFGLTLRTQEVTSRIRtQsFsLQERQLRGAVPWAFDPPG |
| P29474 | T495 | SIGNOR | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30260 | S379 | SIGNOR|EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | tPQVLsPtItsPPNALPRRSsRLFtsDssTTKENsKKLKMK |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32929 | S346 | SIGNOR | CTH | EIFLKNLKLFTLAESLGGFEsLAELPAIMtHASVLKNDRDV |
| P32929 | T355 | SIGNOR | CTH | FTLAESLGGFEsLAELPAIMtHASVLKNDRDVLGISDtLIR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35568 | S794 | ELM | IRS1 | tQRPGEPEEGARHQHLRLSTsSGRLLYAATADDSSSStSSD |
| P35790 | S279 | SIGNOR|PSP | CHKA CHK CKI | EVLRIKFTEESRIKKLHKLLsYNLPLELENLRSLLESTPSP |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36956 | S396 | SIGNOR | SREBF1 BHLHD1 SREBP1 | SNQKLKQENLSLRTAVHKsKsLKDLVSACGSGGNTDVLMEG |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P41235 | S303 | SIGNOR | HNF4A HNF4 NR2A1 TCF14 | DNEyAyLKAIIFFDPDAKGLsDPGKIKRLRsQVQVsLEDYI |
| P41235 | S313 | SIGNOR|ELM|iPTMNet|EPSD | HNF4A HNF4 NR2A1 TCF14 | IFFDPDAKGLsDPGKIKRLRsQVQVsLEDYINDRQYDSRGR |
| P42345 | S1261 | SIGNOR | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | QGDALASGPVETGPMKKLHVstINLQKAWGAARRVSKDDWL |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46937 | S382 | Sugiyama | YAP1 YAP65 | QNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstDsGL |
| P46937 | S94 | SIGNOR | YAP1 YAP65 | NPKtANVPQtVPMRLRKLPDsFFKPPEPKsHsRQAstDAGt |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48764 | S555 | SIGNOR | SLC9A3 NHE3 | FHELNLKDAISYVAEGERRGsLAFIRsPsTDNVVNVDFTPR |
| P48764 | S563 | SIGNOR | SLC9A3 NHE3 | AISYVAEGERRGsLAFIRsPsTDNVVNVDFTPRSSTVEASV |
| P49116 | S351 | SIGNOR | NR2C2 TAK1 TR4 | LADGIDTSGGGSIHVISRDQstPIIEVEGPLLSDTHVTFKL |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49674 | S389 | SIGNOR | CSNK1E | RVDRERKVSMRLHRGAPANVsssDLTGRQEVSRIPAsQtsV |
| P49815 | S1387 | SIGNOR | TSC2 TSC4 | GGRPsVDLsFQPsQPLsKssssPELQtLQDILGDPGDKADV |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50552 | S322 | SIGNOR | VASP | QSEsVRRPWEKNstTLPRMKssssVttsEtQPCtPsSSDyS |
| P50552 | T278 | SIGNOR | VASP | SGGGGLMEEMNAMLARRRKAtQVGEKtPKDEsANQEEPEAR |
| P50552 | T327 | Sugiyama | VASP | RRPWEKNstTLPRMKssssVttsEtQPCtPsSSDySDLQRV |
| P52292 | S105 | SIGNOR|ELM | KPNA2 RCH1 SRP1 | INssNVENQLQATQAARKLLsREKQPPIDNIIRAGLIPKFV |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54646 | S377 | Sugiyama | PRKAA2 AMPK AMPK2 | MHIPPGLKPHPERMPPLIADsPKARCPLDALNTTKPKSLAV |
| P54646 | S481 | Sugiyama | PRKAA2 AMPK AMPK2 | DNRSYLLDFKSIDDEVVEQRsGsstPQRSCsAAGLHRPRss |
| P54646 | S483 | Sugiyama | PRKAA2 AMPK AMPK2 | RSYLLDFKSIDDEVVEQRsGsstPQRSCsAAGLHRPRssFD |
| P54646 | S484 | Sugiyama | PRKAA2 AMPK AMPK2 | SYLLDFKSIDDEVVEQRsGsstPQRSCsAAGLHRPRssFDs |
| P54646 | S54 | Sugiyama | PRKAA2 AMPK AMPK2 | EHQLTGHKVAVKILNRQKIRsLDVVGKIKREIQNLKLFRHP |
| P54646 | T172 | ELM|PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54646 | T485 | Sugiyama | PRKAA2 AMPK AMPK2 | YLLDFKSIDDEVVEQRsGsstPQRSCsAAGLHRPRssFDst |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54840 | S8 | SIGNOR | GYS2 | _____________MLRGRSLsVTSLGGLPQWEVEELPVEEL |
| P55011 | S77 | SIGNOR | SLC12A2 NKCC1 | RDEGPAAAGDGLGRPLGPtPsQsRFQVDLVSENAGRAAAAA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55212 | S257 | ELM | CASP6 MCH2 | GKYGSSLEFTELLTLVNRKVsQRRVDFCKDPSAIGKKQVPC |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60891 | S180 | SIGNOR | PRPS1 | SEWRNCTIVSPDAGGAKRVTsIADRLNVDFALIHKERKKAN |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q05469 | S855 | SIGNOR|ELM | LIPE | SGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKNLT |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09472 | S89 | ELM | EP300 P300 | GMVQDAASKHKQLSELLRsGssPNLNMGVGGPGQVMAsQAQ |
| Q12888 | S1317 | PSP | TP53BP1 | GDLGDISSFSSKAssLHRtssGtsLsAMHSSGssGKGAGPL |
| Q13085 | S1201 | ELM | ACACA ACAC ACC1 ACCA | QFMLPTSHPNRGNIPTLNRMsFssNLNHyGMtHVAsVsDVL |
| Q13085 | S80 | SIGNOR|ELM|EPSD|PSP | ACACA ACAC ACC1 ACCA | sDLGISSLQDGLALHIRssMsGLHLVKQGRDRKKIDSQRDF |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13131 | S486 | SIGNOR | PRKAA1 AMPK1 | DsRTYLLDFRsIDDEItEAKsGtAtPQRsGsVsNYRSCQRs |
| Q13131 | S65 | Sugiyama | PRKAA1 AMPK1 | KHELTGHKVAVKILNRQKIRsLDVVGKIRREIQNLKLFRHP |
| Q13177 | S20 | SIGNOR|EPSD|PSP | PAK2 | _MsDNGELEDKPPAPPVRMsstIFsTGGKDPLsANHsLKPL |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13363 | S158 | SIGNOR | CTBP1 CTBP | NLYRRAtWLHQALREGTRVQsVEQIREVASGAARIRGETLG |
| Q13393 | S505 | SIGNOR|EPSD|PSP | PLD1 | GRWDDNEHRLTDVGsVKRVtsGPsLGSLPPAAMEsMEsLRL |
| Q13621 | S122 | SIGNOR | SLC12A1 NKCC2 | GHNtMDAVPKIEYYRNtGsIsGPKVNRPsLLEIHEQLAKNV |
| Q13625 | S480 | Sugiyama | TP53BP2 ASPP2 BBP | FDAVDQSNAPPSFGTLRKNQssEDILRDAQVANKNVAKVPP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14524 | T101 | SIGNOR | SCN5A | EDLDPFYSTQKTFIVLNKGKtIFRFSATNALYVLSPFHPIR |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16526 | S280 | SIGNOR | CRY1 PHLL1 | LSCRLFYFKLTDLYKKVKKNsSPPLSLYGQLLWREFFYTAA |
| Q16526 | S71 | SIGNOR | CRY1 PHLL1 | RWRFLLQCLEDLDANLRKLNsRLFVIRGQPADVFPRLFKEW |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S314 | SIGNOR | RBBP7 RBAP46 | DKTVALWDLRNLKLKLHTFEsHKDEIFQVHWSPHNETILAS |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q16875 | S461 | SIGNOR|ELM | PFKFB3 | THRERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEE |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q53ET0 | S170 | SIGNOR | CRTC2 TORC2 | GNFPAEKGQLFRLPSALNRtssDsALHtsVMNPsPQDtYPG |
| Q53ET0 | S171 | SIGNOR | CRTC2 TORC2 | NFPAEKGQLFRLPSALNRtssDsALHtsVMNPsPQDtYPGP |
| Q5SYE7 | S1495 | Sugiyama | NHSL1 C6orf63 KIAA1357 | KNRRAQEEWAKNEGLMPRsLsFsGPRYGRSRTPPSAASSRY |
| Q5T5Y3 | S1398 | Sugiyama | CAMSAP1 | sCSDsGTKCSSTPDNLSRtQsGssLsLAsAAttEPESVHSG |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6N021 | S99 | SIGNOR | TET2 KIAA1546 Nbla00191 | TQESRGYSKCLQNGGIKRtVsEPsLSGLLQIKKLKQDQKAN |
| Q6TCH7 | T32 | SIGNOR | PAQR3 | IELGSYQYWPVLVPRGIRLYtYEQIPGSLKDNPYITDGYRA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z3C6 | S761 | SIGNOR | ATG9A APG9L1 | sAPDEGGEGARAPQSIPRsAsYPCAAPRPGAPETTALHGGF |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86TI0 | S237 | SIGNOR|PSP | TBC1D1 KIAA1108 | PHAAPTGSQEPVRRPMRKsFsQPGLRSLAFRKELQDGGLRs |
| Q86TI0 | T596 | PSP | TBC1D1 KIAA1108 | HLPEEPAPLsPQQAFRRRANtLsHFPIECQEPPQPARGsPG |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IY63 | S793 | SIGNOR | AMOTL1 | QQRSRKDAGKTDsssLRPARsVPsIAAATGtHsRQtsLtSS |
| Q8N122 | S722 | SIGNOR | RPTOR KIAA1303 RAPTOR | GGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQNL |
| Q8N122 | S792 | SIGNOR|PSP | RPTOR KIAA1303 RAPTOR | PENEEHILSFETIDKMRRAssYSSLNSLIGVSFNSVYTQIW |
| Q8N2F6 | S45 | SIGNOR|PSP | ARMC10 SVH PSEC0198 | YRLTRGRRRGDRELGIRssKsAGALEEGtsEGQLCGRSARP |
| Q8N806 | S265 | Sugiyama | UBR7 C14orf130 | KDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESKSG |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8ND76 | S326 | SIGNOR | CCNY C10orf9 CBCP1 CFP1 | SRLCEDKYKDLRRSARKRsAsADNLtLPRWsPAIIS_____ |
| Q8NE86 | S57 | SIGNOR | MCU C10orf42 CCDC109A | LGVSRHRQQQHHRTVHQRIAsWQNLGAVYCSTVVPSDDVTV |
| Q8WUF5 | S102 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | RGsPRKAATDGADtPFGRsEsAPtLHPysPLsPKGRPssPR |
| Q8WUI4 | S155 | SIGNOR | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WUI4 | S358 | SIGNOR | HDAC7 HDAC7A | LMTTERLSGSGLHWPLSRtRsEPLPPSATAPPPPGPMQPRL |
| Q8WUI4 | S405 | Sugiyama | HDAC7 HDAC7A | VQVIKRSAKPSEKPRLRQIPsAEDLEtDGGGPGQVVDDGLE |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q92786 | S79 | SIGNOR|PSP | PROX1 | VQHADGEKSNVLRKLLKRANsYEDAMMPFPGATIISQLLKN |
| Q92819 | T110 | SIGNOR|EPSD|PSP | HAS2 | AAYQEDPDYLRKCLQSVKRLtYPGIKVVMVIDGNSEDDLYM |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96L92 | S51 | Sugiyama | SNX27 KIAA0488 My014 | AGNGGGGGGGPRVVRIVKsEsGYGFNVRGQVsEGGQLRSIN |
| Q96P16 | S285 | Sugiyama | RPRD1A P15RS | YKRKLARVSLVRKELRSRIQsLPDLSRLPNVTGSHMHLPFA |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96PU5 | S795 | SIGNOR | NEDD4L KIAA0439 NEDL3 | FCIDEENFGQTYQVDLKPNGsEIMVTNENKREYIDLVIQWR |
| Q99961 | S64 | Sugiyama | SH3GL1 CNSA1 SH3D2B | SKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKIRGQVKNP |
| Q99962 | S64 | Sugiyama | SH3GL2 CNSA2 SH3D2A | SRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKIRGQEKGP |
| Q9BRK0 | S150 | PSP | REEP2 C5orf19 SGC32445 | ANAAVTAAAKGVLSEKLRSFsMQDLTLIRDEDALPLQRPDG |
| Q9BU19 | S470 | SIGNOR | ZNF692 AREBP ZFP692 | CEFCGKRFEKPDSVAAHRSKsHPALLLAPQESPSGPLEPCP |
| Q9BXM7 | S228 | EPSD|PSP | PINK1 | APGAPAFPLAIKMMWNISAGsSSEAILNTMSQELVPASRVA |
| Q9BXM7 | S284 | EPSD|PSP | PINK1 | GPKQLAPHPNIIRVLRAFTSsVPLLPGALVDYPDVLPSRLH |
| Q9BXM7 | S495 | EPSD|PSP | PINK1 | PESVPPDVRQLVRALLQREAsKRPSARVAANVLHLSLWGEH |
| Q9BZL4 | S452 | SIGNOR|EPSD|PSP | PPP1R12C LENG3 MBS85 | GPPERRTAEGAPGAGLQRsAsssWLEGTSTQAKELRLARIT |
| Q9GZY8 | S155 | SIGNOR | MFF C2orf33 AD030 AD033 GL004 | PPttPQNEEIRAVGRLKRERsMsENAVRQNGQLVRNDsLWH |
| Q9GZY8 | S172 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | RERsMsENAVRQNGQLVRNDsLWHRsDsAPRNKISRFQAPI |
| Q9H0B6 | S582 | SIGNOR | KLC2 | KKLQGGtPQEPPNPRMKRAssLNFLNKsVEEPTQPGGTGLs |
| Q9H2X6 | S121 | SIGNOR|PSP | HIPK2 | TSVTGQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIENT |
| Q9H2X6 | T1114 | PSP | HIPK2 | AHLPTQPHLYTYTAPAALGStGtVAHLVASQGSARHTVQHT |
| Q9H2X6 | T1116 | SIGNOR | HIPK2 | LPTQPHLYTYTAPAALGStGtVAHLVASQGSARHTVQHTAY |
| Q9H2X6 | T119 | SIGNOR|PSP | HIPK2 | SSTSVTGQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIE |
| Q9H3M7 | S308 | SIGNOR | TXNIP VDUP1 | VILDLPLVIGSRSGLSSRTSsMASRTSSEMSWVDLNIPDTP |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9H902 | S152 | PSP | REEP1 C2orf23 SPG31 | AAVMAASKGQGALSERLRSFsMQDLTTIRGDGAPAPSGPPP |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9NP71 | S556 | SIGNOR | MLXIPL BHLHD14 MIO WBSCR14 | KPEQALEPPLVSSTLLRSPGsPQETVPEFPCTFLPPTPAPT |
| Q9NQP4 | S125 | Sugiyama | PFDN4 PFD4 | VEsIQRVLADLKVQLYAKFGsNINLEADEs___________ |
| Q9NR19 | S659 | SIGNOR | ACSS2 ACAS2 | IGPIAtPDYIQNAPGLPKTRsGKIMRRVLRKIAQNDHDLGD |
| Q9NRC8 | T153 | SIGNOR | SIRT7 SIR2L7 | RsVsAADLSEAEPTLTHMSItRLHEQKLVQHVVSQNCDGLH |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NSK0 | S590 | PSP | KLC4 KNSL8 | VRKLQGTEPRPSSSNMKRAAsLNyLNQPsAAPLQVSRGLsA |
| Q9NVU7 | T552 | Sugiyama | SDAD1 NUC130 | SMPMEERKAKAAAISTSRVLtQEDFQKIRMAQMRKELDAAP |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NYV6 | S635 | SIGNOR | RRN3 TIFIA | QNDTVIGItPSsFDtHFRsPsssVGsPPVLyMQPsPL____ |
| Q9UBK2 | S539 | SIGNOR | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | DKLSYPWDGTQSYSLFNVSPsCSSFNSPCRDSVSPPKSLFS |
| Q9UBK2 | T178 | SIGNOR | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | YNECSGLSTQNHANHNHRIRtNPAIVKTENSWSNKAKSICQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UNF1 | S85 | Sugiyama | MAGED2 BCG1 | KAtEVsKtPEAREAPAtQAssttQLtDtQVLAAENKSLAAD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQB8 | S366 | SIGNOR|EPSD|PSP | BAIAP2 | SVTPKNSYATtENKtLPRsssMAAGLERNGRMRVKAIFsHA |
| Q9UQK1 | S33 | SIGNOR | PPP1R3C PPP1R5 | RPLTSSVMPVDVAMRLCLAHsPPVKSFLGPYDEFQRRHFVN |
| Q9UQL6 | S259 | SIGNOR|EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR|EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y243 | S472 | Sugiyama | AKT3 PKBG | YDEDGMDCMDNERRPHFPQFsysAsGRE_____________ |
| Q9Y243 | S474 | Sugiyama | AKT3 PKBG | EDGMDCMDNERRPHFPQFsysAsGRE_______________ |
| Q9Y243 | S476 | Sugiyama | AKT3 PKBG | GMDCMDNERRPHFPQFsysAsGRE_________________ |
| Q9Y243 | Y473 | Sugiyama | AKT3 PKBG | DEDGMDCMDNERRPHFPQFsysAsGRE______________ |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2I7 | S307 | SIGNOR | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2T7 | T115 | SIGNOR | YBX2 CSDA3 MSY2 | LGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIKRNNPRKFL |
| Q9Y478 | S101 | Sugiyama | PRKAB1 AMPK | VFRWTGGGKEVYLSGsFNNWsKLPLtRsHNNFVAILDLPEG |
| Q9Y478 | S170 | Sugiyama | PRKAB1 AMPK | NNIIQVKKtDFEVFDALMVDsQKCsDVsELsssPPGPyHQE |
| Q9Y478 | S40 | Sugiyama | PRKAB1 AMPK | PRRDssGGTKDGDRPKILMDsPEDADLFHsEEIKAPEKEEF |
| Q9Y478 | S49 | Sugiyama | PRKAB1 AMPK | KDGDRPKILMDsPEDADLFHsEEIKAPEKEEFLAWQHDLEV |
| Q9Y478 | S96 | Sugiyama | PRKAB1 AMPK | QARPtVFRWTGGGKEVYLSGsFNNWsKLPLtRsHNNFVAIL |
| Q9Y478 | T158 | Sugiyama | PRKAB1 AMPK | SEPIVTSQLGtVNNIIQVKKtDFEVFDALMVDsQKCsDVsE |
| Q9Y478 | T80 | Sugiyama | PRKAB1 AMPK | FLAWQHDLEVNDKAPAQARPtVFRWTGGGKEVYLSGsFNNW |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| NRAGE signals death through JNK | R-HSA-193648 | 8.376700e-08 | 7.077 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.068086e-07 | 6.971 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.644468e-07 | 6.784 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.680706e-07 | 6.775 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.088876e-07 | 6.510 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.670993e-07 | 6.331 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.129110e-07 | 6.040 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.011347e-06 | 5.521 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.079796e-06 | 5.294 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.160657e-06 | 5.145 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.940036e-05 | 4.712 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.940036e-05 | 4.712 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.419285e-05 | 4.466 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.459760e-05 | 4.351 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.356763e-05 | 4.361 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.292173e-05 | 4.367 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.784082e-05 | 4.320 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.725453e-05 | 4.059 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.335101e-04 | 3.874 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.432137e-04 | 3.844 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.707661e-04 | 3.768 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.963981e-04 | 3.707 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.101974e-04 | 3.677 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.135580e-04 | 3.670 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.136034e-04 | 3.670 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.933631e-04 | 3.533 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.255063e-04 | 3.487 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.412323e-04 | 3.467 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.899182e-04 | 3.229 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.819781e-04 | 3.235 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.555985e-04 | 3.183 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.083515e-04 | 3.150 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.854998e-04 | 3.105 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.750318e-04 | 3.058 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.750318e-04 | 3.058 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.750318e-04 | 3.058 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.750318e-04 | 3.058 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.265242e-04 | 3.033 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.546064e-04 | 3.020 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.605089e-04 | 3.017 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.801778e-04 | 3.009 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.071963e-03 | 2.970 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.112482e-03 | 2.954 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.196548e-03 | 2.922 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.334388e-03 | 2.875 | 1 | 1 |
| Activation of RAC1 | R-HSA-428540 | 1.507062e-03 | 2.822 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.763500e-03 | 2.754 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.763500e-03 | 2.754 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.736863e-03 | 2.760 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.880995e-03 | 2.726 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.936122e-03 | 2.713 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.075053e-03 | 2.683 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.008921e-03 | 2.697 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.080038e-03 | 2.682 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.765745e-03 | 2.558 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.098401e-03 | 2.509 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.257693e-03 | 2.487 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.525825e-03 | 2.453 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.125437e-03 | 2.385 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.130741e-03 | 2.384 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.130741e-03 | 2.384 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.053480e-03 | 2.392 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.239353e-03 | 2.373 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.261009e-03 | 2.370 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.261009e-03 | 2.370 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.591020e-03 | 2.338 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.612966e-03 | 2.336 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.224768e-03 | 2.282 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.111101e-03 | 2.291 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.850436e-03 | 2.314 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.856794e-03 | 2.314 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.235243e-03 | 2.281 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.109751e-03 | 2.292 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.681431e-03 | 2.246 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.681431e-03 | 2.246 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.451571e-03 | 2.263 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.689853e-03 | 2.245 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.880222e-03 | 2.231 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.571726e-03 | 2.254 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.850616e-03 | 2.233 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.681431e-03 | 2.246 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.959283e-03 | 2.225 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.969136e-03 | 2.224 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.017687e-03 | 2.221 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.355660e-03 | 2.197 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.355660e-03 | 2.197 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.487568e-03 | 2.188 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.684356e-03 | 2.175 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.715318e-03 | 2.173 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.877608e-03 | 2.163 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.877608e-03 | 2.163 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.667578e-03 | 2.115 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.667578e-03 | 2.115 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.482089e-03 | 2.126 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.672990e-03 | 2.115 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.827669e-03 | 2.106 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.135627e-03 | 2.090 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.242157e-03 | 2.084 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.290041e-03 | 2.081 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.540643e-03 | 2.069 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.824757e-03 | 2.054 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.031523e-03 | 2.044 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.167337e-03 | 2.038 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.522748e-03 | 2.021 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.001403e-02 | 1.999 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.001403e-02 | 1.999 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.001403e-02 | 1.999 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.001403e-02 | 1.999 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.001403e-02 | 1.999 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.541966e-03 | 2.020 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.080269e-02 | 1.966 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.058958e-02 | 1.975 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.058958e-02 | 1.975 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.058958e-02 | 1.975 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.059664e-02 | 1.975 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.080425e-02 | 1.966 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.117081e-02 | 1.952 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.215099e-02 | 1.915 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.222452e-02 | 1.913 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.267927e-02 | 1.897 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.272736e-02 | 1.895 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.285055e-02 | 1.891 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.383714e-02 | 1.859 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.387359e-02 | 1.858 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.373914e-02 | 1.862 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.493294e-02 | 1.826 | 1 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.494357e-02 | 1.826 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.521651e-02 | 1.818 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.534263e-02 | 1.814 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.617335e-02 | 1.791 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.617335e-02 | 1.791 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.795500e-02 | 1.746 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.762472e-02 | 1.754 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.762472e-02 | 1.754 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.777699e-02 | 1.750 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.755931e-02 | 1.755 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.752132e-02 | 1.756 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.797959e-02 | 1.745 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.950125e-02 | 1.710 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.950125e-02 | 1.710 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.950125e-02 | 1.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.950125e-02 | 1.710 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.939920e-02 | 1.712 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.934159e-02 | 1.714 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.886223e-02 | 1.724 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.015211e-02 | 1.696 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.935404e-02 | 1.713 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.033224e-02 | 1.692 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.068809e-02 | 1.684 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.068809e-02 | 1.684 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.074059e-02 | 1.683 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.074059e-02 | 1.683 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.078973e-02 | 1.682 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.085967e-02 | 1.681 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.085967e-02 | 1.681 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.161404e-02 | 1.665 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.199957e-02 | 1.658 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.448591e-02 | 1.611 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.430672e-02 | 1.614 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.245800e-02 | 1.649 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.334326e-02 | 1.632 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.322050e-02 | 1.634 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.448591e-02 | 1.611 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.670832e-02 | 1.573 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.717146e-02 | 1.566 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.717146e-02 | 1.566 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.717146e-02 | 1.566 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.717146e-02 | 1.566 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.717146e-02 | 1.566 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.717146e-02 | 1.566 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.749699e-02 | 1.561 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.815405e-02 | 1.550 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.815405e-02 | 1.550 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.865750e-02 | 1.543 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.865750e-02 | 1.543 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.874882e-02 | 1.541 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.907713e-02 | 1.536 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.025234e-02 | 1.519 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.375182e-02 | 1.472 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.377334e-02 | 1.471 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.455871e-02 | 1.461 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.351773e-02 | 1.475 | 1 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.440393e-02 | 1.463 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.217423e-02 | 1.492 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.487304e-02 | 1.458 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.487304e-02 | 1.458 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.582475e-02 | 1.446 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.713891e-02 | 1.430 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.816167e-02 | 1.418 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.825984e-02 | 1.417 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.841188e-02 | 1.416 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.853076e-02 | 1.414 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.938101e-02 | 1.405 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.938101e-02 | 1.405 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.955792e-02 | 1.403 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.986823e-02 | 1.399 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.231758e-02 | 1.373 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.282204e-02 | 1.368 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.961189e-02 | 1.304 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.961189e-02 | 1.304 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.961189e-02 | 1.304 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.961189e-02 | 1.304 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.710352e-02 | 1.327 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.559735e-02 | 1.341 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.639481e-02 | 1.334 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.797830e-02 | 1.319 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.797830e-02 | 1.319 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.366383e-02 | 1.360 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.797830e-02 | 1.319 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.385524e-02 | 1.358 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.408098e-02 | 1.356 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.979463e-02 | 1.303 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.996451e-02 | 1.301 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.039348e-02 | 1.298 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.244440e-02 | 1.280 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.244440e-02 | 1.280 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.244440e-02 | 1.280 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.341839e-02 | 1.272 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.374319e-02 | 1.270 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.374319e-02 | 1.270 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.374319e-02 | 1.270 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.374319e-02 | 1.270 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.412980e-02 | 1.267 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.413705e-02 | 1.267 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.413705e-02 | 1.267 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.416131e-02 | 1.266 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.420136e-02 | 1.266 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.420136e-02 | 1.266 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.420136e-02 | 1.266 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.425497e-02 | 1.266 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.512391e-02 | 1.259 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.568324e-02 | 1.254 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.568324e-02 | 1.254 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.682129e-02 | 1.245 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.708221e-02 | 1.243 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.179308e-02 | 1.209 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.158963e-02 | 1.210 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.725580e-02 | 1.242 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.652426e-02 | 1.177 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.737192e-02 | 1.241 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.274091e-02 | 1.202 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.179308e-02 | 1.209 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.274091e-02 | 1.202 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.274091e-02 | 1.202 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.581482e-02 | 1.182 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.994047e-02 | 1.222 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.444558e-02 | 1.191 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.444558e-02 | 1.191 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.736869e-02 | 1.172 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 6.736869e-02 | 1.172 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.736869e-02 | 1.172 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.800123e-02 | 1.167 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.809983e-02 | 1.167 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.942931e-02 | 1.158 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.165220e-02 | 1.145 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.165220e-02 | 1.145 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.181528e-02 | 1.144 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.490226e-02 | 1.126 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.572692e-02 | 1.121 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.661356e-02 | 1.116 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.693249e-02 | 1.114 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.721452e-02 | 1.112 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.721452e-02 | 1.112 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.721452e-02 | 1.112 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.721452e-02 | 1.112 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.721452e-02 | 1.112 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.750169e-02 | 1.111 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.763867e-02 | 1.110 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.780373e-02 | 1.109 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.881969e-02 | 1.103 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.098197e-02 | 1.041 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.098197e-02 | 1.041 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.098197e-02 | 1.041 | 1 | 1 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.316088e-02 | 1.031 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.316088e-02 | 1.031 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.010847e-02 | 1.045 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.625463e-02 | 1.064 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.376447e-02 | 1.077 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.839746e-02 | 1.054 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.517666e-02 | 1.021 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.905087e-02 | 1.050 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.279657e-02 | 1.032 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.098197e-02 | 1.041 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.214749e-02 | 1.036 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.597575e-02 | 1.066 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.765274e-02 | 1.057 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.985437e-02 | 1.046 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.149734e-02 | 1.089 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.472300e-02 | 1.024 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.095270e-02 | 1.092 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.959983e-02 | 1.048 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.098197e-02 | 1.041 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.272054e-02 | 1.082 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.316088e-02 | 1.031 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.272054e-02 | 1.082 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.604786e-02 | 1.018 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.663594e-02 | 1.015 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.663594e-02 | 1.015 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.689256e-02 | 1.014 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.706183e-02 | 1.013 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.706183e-02 | 1.013 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.795340e-02 | 1.009 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.795340e-02 | 1.009 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.795340e-02 | 1.009 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.795340e-02 | 1.009 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.035586e-01 | 0.985 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.043712e-01 | 0.981 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.043712e-01 | 0.981 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.043712e-01 | 0.981 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.046452e-01 | 0.980 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.046452e-01 | 0.980 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.046452e-01 | 0.980 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.046452e-01 | 0.980 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.046452e-01 | 0.980 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.050305e-01 | 0.979 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.052887e-01 | 0.978 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.088054e-01 | 0.963 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.088054e-01 | 0.963 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.088054e-01 | 0.963 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.088054e-01 | 0.963 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.310547e-01 | 0.883 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.310547e-01 | 0.883 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.094992e-01 | 0.961 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.094992e-01 | 0.961 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.094992e-01 | 0.961 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.346860e-01 | 0.871 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.346860e-01 | 0.871 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.128638e-01 | 0.947 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.368190e-01 | 0.864 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.323901e-01 | 0.878 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.323901e-01 | 0.878 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.339637e-01 | 0.873 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.157345e-01 | 0.937 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.327254e-01 | 0.877 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.179990e-01 | 0.928 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.297966e-01 | 0.887 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.136115e-01 | 0.945 | 1 | 1 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.128638e-01 | 0.947 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.128638e-01 | 0.947 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.286599e-01 | 0.891 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.169525e-01 | 0.932 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.157345e-01 | 0.937 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.214873e-01 | 0.915 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.368190e-01 | 0.864 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.346860e-01 | 0.871 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.230744e-01 | 0.910 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.128638e-01 | 0.947 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.183009e-01 | 0.927 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.230744e-01 | 0.910 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.312378e-01 | 0.882 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.391544e-01 | 0.857 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.437921e-01 | 0.842 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.437921e-01 | 0.842 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.439521e-01 | 0.842 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.440740e-01 | 0.841 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.448392e-01 | 0.839 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.448392e-01 | 0.839 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.449958e-01 | 0.839 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.487433e-01 | 0.828 | 1 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.505901e-01 | 0.822 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.505901e-01 | 0.822 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.507097e-01 | 0.822 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.511313e-01 | 0.821 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.528349e-01 | 0.816 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.536773e-01 | 0.813 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.536773e-01 | 0.813 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.536773e-01 | 0.813 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.536773e-01 | 0.813 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.536773e-01 | 0.813 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.449406e-01 | 0.611 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.449406e-01 | 0.611 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.449406e-01 | 0.611 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.449406e-01 | 0.611 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.449406e-01 | 0.611 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.449406e-01 | 0.611 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.449406e-01 | 0.611 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.566074e-01 | 0.805 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.066665e-01 | 0.685 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.066665e-01 | 0.685 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.066665e-01 | 0.685 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.439061e-01 | 0.464 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.439061e-01 | 0.464 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.439061e-01 | 0.464 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.439061e-01 | 0.464 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective APRT disrupts adenine salvage | R-HSA-9734195 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.439061e-01 | 0.464 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.439061e-01 | 0.464 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.439061e-01 | 0.464 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.439061e-01 | 0.464 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.439061e-01 | 0.464 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.439061e-01 | 0.464 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.439061e-01 | 0.464 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.439061e-01 | 0.464 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.439061e-01 | 0.464 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.439061e-01 | 0.464 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.675962e-01 | 0.776 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.675962e-01 | 0.776 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.675962e-01 | 0.776 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.675962e-01 | 0.776 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.675962e-01 | 0.776 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.580947e-01 | 0.588 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.580947e-01 | 0.588 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.580947e-01 | 0.588 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.580947e-01 | 0.588 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.025366e-01 | 0.693 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.025366e-01 | 0.693 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.025366e-01 | 0.693 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.025366e-01 | 0.693 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.025366e-01 | 0.693 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.025366e-01 | 0.693 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.626148e-01 | 0.789 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.626148e-01 | 0.789 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.899984e-01 | 0.721 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.899984e-01 | 0.721 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.389624e-01 | 0.622 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.389624e-01 | 0.622 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.389624e-01 | 0.622 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.096739e-01 | 0.509 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.096739e-01 | 0.509 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.096739e-01 | 0.509 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.096739e-01 | 0.509 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.096739e-01 | 0.509 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.096739e-01 | 0.509 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.096739e-01 | 0.509 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.096739e-01 | 0.509 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.096739e-01 | 0.509 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.299052e-01 | 0.367 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.299052e-01 | 0.367 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.299052e-01 | 0.367 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.299052e-01 | 0.367 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.299052e-01 | 0.367 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.762742e-01 | 0.754 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.187058e-01 | 0.660 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.763641e-01 | 0.559 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.763641e-01 | 0.559 | 1 | 1 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.763641e-01 | 0.559 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.484706e-01 | 0.605 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.681258e-01 | 0.774 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.247996e-01 | 0.648 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.142774e-01 | 0.503 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.142774e-01 | 0.503 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.707265e-01 | 0.768 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.790302e-01 | 0.554 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.790302e-01 | 0.554 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.790302e-01 | 0.554 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.566711e-01 | 0.805 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.263512e-01 | 0.645 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.056711e-01 | 0.687 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.051974e-01 | 0.688 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.255386e-01 | 0.647 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.255386e-01 | 0.647 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.101314e-01 | 0.508 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.101314e-01 | 0.508 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.101314e-01 | 0.508 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.522883e-01 | 0.453 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.522883e-01 | 0.453 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.098346e-01 | 0.387 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.098346e-01 | 0.387 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.098346e-01 | 0.387 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.098346e-01 | 0.387 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.098346e-01 | 0.387 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.046361e-01 | 0.297 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.046361e-01 | 0.297 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.046361e-01 | 0.297 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.046361e-01 | 0.297 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.046361e-01 | 0.297 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.046361e-01 | 0.297 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.046361e-01 | 0.297 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.460337e-01 | 0.609 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.460337e-01 | 0.609 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.460337e-01 | 0.609 | 1 | 1 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.035243e-01 | 0.518 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.415345e-01 | 0.467 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.415345e-01 | 0.467 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.797888e-01 | 0.745 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.900349e-01 | 0.409 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.900349e-01 | 0.409 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.307058e-01 | 0.481 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.284478e-01 | 0.641 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.015170e-01 | 0.696 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.236893e-01 | 0.650 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.203154e-01 | 0.494 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.203154e-01 | 0.494 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.730163e-01 | 0.428 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.730163e-01 | 0.428 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.572413e-01 | 0.340 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.572413e-01 | 0.340 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.572413e-01 | 0.340 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.439648e-01 | 0.613 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.755087e-01 | 0.756 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.782419e-01 | 0.749 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.447612e-01 | 0.462 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.447612e-01 | 0.462 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.272072e-01 | 0.369 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.272072e-01 | 0.369 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.215306e-01 | 0.493 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.296731e-01 | 0.639 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.693709e-01 | 0.433 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.421449e-01 | 0.466 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.421449e-01 | 0.466 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.421449e-01 | 0.466 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.237474e-01 | 0.650 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.237474e-01 | 0.650 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.129564e-01 | 0.384 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.129564e-01 | 0.384 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.635449e-01 | 0.334 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.635449e-01 | 0.334 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.635449e-01 | 0.334 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.023642e-01 | 0.299 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.023642e-01 | 0.299 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.023642e-01 | 0.299 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.023642e-01 | 0.299 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.695747e-01 | 0.244 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.695747e-01 | 0.244 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.695747e-01 | 0.244 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.695747e-01 | 0.244 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.695747e-01 | 0.244 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.695747e-01 | 0.244 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.695747e-01 | 0.244 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.695747e-01 | 0.244 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.001691e-01 | 0.398 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.659902e-01 | 0.332 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.190274e-01 | 0.496 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.416043e-01 | 0.466 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.819989e-01 | 0.418 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.988350e-01 | 0.302 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.988350e-01 | 0.302 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.988350e-01 | 0.302 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.988350e-01 | 0.302 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.959446e-01 | 0.305 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.959446e-01 | 0.305 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.959446e-01 | 0.305 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.959446e-01 | 0.305 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.449875e-01 | 0.264 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.449875e-01 | 0.264 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.935355e-01 | 0.307 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.935355e-01 | 0.307 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.935355e-01 | 0.307 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.332629e-01 | 0.363 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.914616e-01 | 0.309 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.896296e-01 | 0.310 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.251587e-01 | 0.280 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.864715e-01 | 0.313 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.195146e-01 | 0.284 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.195146e-01 | 0.284 | 1 | 1 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.150880e-01 | 0.288 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.150880e-01 | 0.288 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.083473e-01 | 0.294 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.382815e-01 | 0.269 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.449083e-01 | 0.264 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.449083e-01 | 0.264 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.535290e-01 | 0.257 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.535290e-01 | 0.257 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.656300e-01 | 0.247 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.656300e-01 | 0.247 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.849912e-01 | 0.233 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.849912e-01 | 0.233 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.849912e-01 | 0.233 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.260035e-01 | 0.203 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.260035e-01 | 0.203 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.260035e-01 | 0.203 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.609840e-01 | 0.251 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.696465e-01 | 0.244 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.809703e-01 | 0.236 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.809703e-01 | 0.236 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.969076e-01 | 0.224 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.969076e-01 | 0.224 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.969076e-01 | 0.224 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.223296e-01 | 0.206 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.223296e-01 | 0.206 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.223296e-01 | 0.206 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.223296e-01 | 0.206 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.794677e-01 | 0.237 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.382815e-01 | 0.269 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.693709e-01 | 0.433 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.940415e-01 | 0.404 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.382815e-01 | 0.269 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.936693e-01 | 0.226 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.590513e-01 | 0.798 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.239972e-01 | 0.373 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.590513e-01 | 0.798 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.841073e-01 | 0.547 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.771229e-01 | 0.752 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.504117e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.673907e-01 | 0.330 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.257468e-01 | 0.371 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.850993e-01 | 0.314 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.155182e-01 | 0.501 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.936693e-01 | 0.226 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.973411e-01 | 0.401 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.272072e-01 | 0.369 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.685315e-01 | 0.571 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.112880e-01 | 0.386 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.969076e-01 | 0.224 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.905640e-01 | 0.229 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.905640e-01 | 0.229 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.436222e-01 | 0.464 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.675962e-01 | 0.776 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.104678e-01 | 0.508 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.093936e-01 | 0.509 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.656300e-01 | 0.247 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.061764e-01 | 0.391 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.722538e-01 | 0.326 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.160198e-01 | 0.500 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.905640e-01 | 0.229 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.899984e-01 | 0.721 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.373566e-01 | 0.472 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.433058e-01 | 0.265 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.421449e-01 | 0.466 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.656300e-01 | 0.247 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.223296e-01 | 0.206 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.763641e-01 | 0.559 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.670526e-01 | 0.331 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.959446e-01 | 0.305 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.690671e-01 | 0.245 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.236221e-01 | 0.205 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.803182e-01 | 0.420 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.187058e-01 | 0.660 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.205957e-01 | 0.376 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.617543e-01 | 0.336 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.626148e-01 | 0.789 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.763641e-01 | 0.559 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.763641e-01 | 0.559 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.263512e-01 | 0.645 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.016180e-01 | 0.521 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.449083e-01 | 0.264 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.074150e-01 | 0.217 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.346447e-01 | 0.475 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.155534e-01 | 0.381 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.857490e-01 | 0.731 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.120054e-01 | 0.674 | 1 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.885635e-01 | 0.230 | 1 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.415345e-01 | 0.467 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.421455e-01 | 0.616 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.449083e-01 | 0.264 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.656971e-01 | 0.781 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.675962e-01 | 0.776 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.763641e-01 | 0.559 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.142774e-01 | 0.503 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.098346e-01 | 0.387 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.572413e-01 | 0.340 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.272072e-01 | 0.369 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.023642e-01 | 0.299 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.155534e-01 | 0.381 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.449875e-01 | 0.264 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.329277e-01 | 0.273 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.535290e-01 | 0.257 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.867535e-01 | 0.232 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.223296e-01 | 0.206 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.491507e-01 | 0.348 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.760707e-01 | 0.559 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.014168e-01 | 0.696 | 1 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.150880e-01 | 0.288 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.479483e-01 | 0.349 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.504117e-01 | 0.601 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.956469e-01 | 0.709 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.767070e-01 | 0.558 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.572413e-01 | 0.340 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.001691e-01 | 0.398 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.681258e-01 | 0.774 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.390105e-01 | 0.268 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.580947e-01 | 0.588 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.025366e-01 | 0.693 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.899984e-01 | 0.721 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.899984e-01 | 0.721 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.389624e-01 | 0.622 | 1 | 1 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.604817e-01 | 0.443 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.247996e-01 | 0.648 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.101314e-01 | 0.508 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.272072e-01 | 0.369 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.023642e-01 | 0.299 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.311161e-01 | 0.480 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.490181e-01 | 0.457 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.260035e-01 | 0.203 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.609840e-01 | 0.251 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.160731e-01 | 0.210 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.223296e-01 | 0.206 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.979450e-01 | 0.703 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.348447e-01 | 0.629 | 1 | 1 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.490464e-01 | 0.604 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.535290e-01 | 0.257 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.655044e-01 | 0.781 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.961406e-01 | 0.529 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.891322e-01 | 0.723 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.025366e-01 | 0.693 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.763641e-01 | 0.559 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.900349e-01 | 0.409 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.449083e-01 | 0.264 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.323619e-01 | 0.364 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.000335e-01 | 0.699 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.832187e-01 | 0.737 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.421455e-01 | 0.616 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.898679e-01 | 0.722 | 1 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.626148e-01 | 0.789 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.389624e-01 | 0.622 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.299052e-01 | 0.367 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.522883e-01 | 0.453 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.098346e-01 | 0.387 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.046361e-01 | 0.297 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.844412e-01 | 0.734 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.415345e-01 | 0.467 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.730163e-01 | 0.428 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.572413e-01 | 0.340 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.572413e-01 | 0.340 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.572413e-01 | 0.340 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.572413e-01 | 0.340 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.272072e-01 | 0.369 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.272072e-01 | 0.369 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.043725e-01 | 0.393 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.449875e-01 | 0.264 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.449875e-01 | 0.264 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.790547e-01 | 0.554 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.864715e-01 | 0.313 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.849912e-01 | 0.233 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.260035e-01 | 0.203 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.260035e-01 | 0.203 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.969076e-01 | 0.224 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.050306e-01 | 0.218 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.223296e-01 | 0.206 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.204524e-01 | 0.657 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.671182e-01 | 0.331 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.263512e-01 | 0.645 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.690187e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.104678e-01 | 0.508 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.862079e-01 | 0.730 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.681258e-01 | 0.774 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.142774e-01 | 0.503 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.460337e-01 | 0.609 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.685160e-01 | 0.245 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.658905e-01 | 0.332 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.635449e-01 | 0.334 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.730843e-01 | 0.564 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.724142e-01 | 0.763 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.371568e-01 | 0.472 | 1 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.566074e-01 | 0.805 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.899984e-01 | 0.721 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.187058e-01 | 0.660 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.763641e-01 | 0.559 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.604817e-01 | 0.443 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.681258e-01 | 0.774 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.790302e-01 | 0.554 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.876244e-01 | 0.727 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.522883e-01 | 0.453 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.412985e-01 | 0.617 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.023642e-01 | 0.299 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.695747e-01 | 0.244 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.674678e-01 | 0.330 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.488773e-01 | 0.261 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.074150e-01 | 0.217 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.811239e-01 | 0.551 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.577109e-01 | 0.802 | 1 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.247996e-01 | 0.648 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.654087e-01 | 0.332 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.690014e-01 | 0.245 | 1 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.936693e-01 | 0.226 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.303357e-01 | 0.275 | 1 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.857188e-01 | 0.731 | 1 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.626148e-01 | 0.789 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.789149e-01 | 0.747 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.635449e-01 | 0.334 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.114458e-01 | 0.291 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.656300e-01 | 0.247 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.531187e-01 | 0.257 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.465594e-01 | 0.262 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.055085e-01 | 0.687 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.055085e-01 | 0.687 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.567304e-01 | 0.591 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.338318e-01 | 0.631 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.762663e-01 | 0.239 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.029057e-01 | 0.693 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.580997e-01 | 0.446 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.074032e-01 | 0.512 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.627089e-01 | 0.250 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.140929e-01 | 0.669 | 1 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.722201e-01 | 0.429 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.564849e-01 | 0.448 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.588917e-01 | 0.799 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.706687e-01 | 0.568 | 1 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.066665e-01 | 0.685 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.675962e-01 | 0.776 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.580947e-01 | 0.588 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.389624e-01 | 0.622 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.096739e-01 | 0.509 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.299052e-01 | 0.367 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.763641e-01 | 0.559 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.681258e-01 | 0.774 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.247996e-01 | 0.648 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.043726e-01 | 0.690 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.142774e-01 | 0.503 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.046361e-01 | 0.297 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.013698e-01 | 0.696 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.900349e-01 | 0.409 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.572413e-01 | 0.340 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.572413e-01 | 0.340 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.572413e-01 | 0.340 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.572413e-01 | 0.340 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.911204e-01 | 0.719 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.984558e-01 | 0.525 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.047984e-01 | 0.393 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.136274e-01 | 0.383 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.914616e-01 | 0.309 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.260035e-01 | 0.203 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.831442e-01 | 0.234 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.074150e-01 | 0.217 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.223296e-01 | 0.206 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.841073e-01 | 0.547 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.825531e-01 | 0.316 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.001691e-01 | 0.398 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.072745e-01 | 0.295 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.170369e-01 | 0.663 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.062996e-01 | 0.514 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.911566e-01 | 0.309 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.865090e-01 | 0.729 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.988350e-01 | 0.302 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.609840e-01 | 0.251 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.449083e-01 | 0.264 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.996033e-01 | 0.398 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.790302e-01 | 0.554 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.862079e-01 | 0.730 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.352152e-01 | 0.629 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.695747e-01 | 0.244 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.819989e-01 | 0.418 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.656300e-01 | 0.247 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.142606e-01 | 0.669 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.033403e-01 | 0.692 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.674678e-01 | 0.330 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.885814e-01 | 0.540 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.323619e-01 | 0.364 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.237116e-01 | 0.490 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.096739e-01 | 0.509 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.098346e-01 | 0.387 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.580997e-01 | 0.446 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.695747e-01 | 0.244 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.659902e-01 | 0.332 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.260035e-01 | 0.203 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.177715e-01 | 0.286 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.685160e-01 | 0.245 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.165182e-01 | 0.210 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.056711e-01 | 0.687 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.988941e-01 | 0.223 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 3.043206e-01 | 0.517 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.493558e-01 | 0.347 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.670755e-01 | 0.573 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.001691e-01 | 0.398 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.112880e-01 | 0.386 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.168484e-01 | 0.499 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.312379e-01 | 0.365 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.043725e-01 | 0.393 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.047839e-01 | 0.218 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.580997e-01 | 0.446 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.298278e-01 | 0.367 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.900349e-01 | 0.409 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.307058e-01 | 0.481 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.209329e-01 | 0.283 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.969076e-01 | 0.224 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.704785e-01 | 0.431 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.439061e-01 | 0.464 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.096739e-01 | 0.509 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.299052e-01 | 0.367 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.142774e-01 | 0.503 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.790302e-01 | 0.554 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.255386e-01 | 0.647 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.307058e-01 | 0.481 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.023642e-01 | 0.299 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.695747e-01 | 0.244 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.695747e-01 | 0.244 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.227373e-01 | 0.374 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 5.449875e-01 | 0.264 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 5.449875e-01 | 0.264 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.032464e-01 | 0.298 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.260035e-01 | 0.203 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.897180e-01 | 0.229 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.653602e-01 | 0.576 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.504117e-01 | 0.601 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.251587e-01 | 0.280 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.514599e-01 | 0.600 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.535290e-01 | 0.257 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.679326e-01 | 0.434 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.025366e-01 | 0.693 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.272072e-01 | 0.369 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.272072e-01 | 0.369 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.272072e-01 | 0.369 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.809703e-01 | 0.236 | 1 | 1 |
| Histamine receptors | R-HSA-390650 | 5.046361e-01 | 0.297 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.452144e-01 | 0.351 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.675329e-01 | 0.330 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.849912e-01 | 0.233 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.832795e-01 | 0.416 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.653150e-01 | 0.437 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.669851e-01 | 0.574 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.299052e-01 | 0.367 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.098346e-01 | 0.387 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.098346e-01 | 0.387 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.695747e-01 | 0.244 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.695747e-01 | 0.244 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.449875e-01 | 0.264 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 4.914616e-01 | 0.309 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.803182e-01 | 0.420 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.999472e-01 | 0.523 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.674678e-01 | 0.330 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.504117e-01 | 0.601 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.284484e-01 | 0.277 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.809703e-01 | 0.236 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.837156e-01 | 0.736 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.096739e-01 | 0.509 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.790302e-01 | 0.554 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.098346e-01 | 0.387 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.900349e-01 | 0.409 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.023642e-01 | 0.299 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.023642e-01 | 0.299 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.535290e-01 | 0.257 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.260035e-01 | 0.203 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.637968e-01 | 0.249 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.975739e-01 | 0.224 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.043725e-01 | 0.393 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.378051e-01 | 0.269 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 4.043725e-01 | 0.393 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.959446e-01 | 0.305 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.251587e-01 | 0.280 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.212347e-01 | 0.283 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.023642e-01 | 0.299 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.272072e-01 | 0.369 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.256669e-01 | 0.204 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.449875e-01 | 0.264 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.940415e-01 | 0.404 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.266741e-01 | 0.203 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.266741e-01 | 0.203 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.266741e-01 | 0.203 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.266741e-01 | 0.203 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.266741e-01 | 0.203 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.266741e-01 | 0.203 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.266741e-01 | 0.203 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.328112e-01 | 0.199 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.328112e-01 | 0.199 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.328112e-01 | 0.199 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.328112e-01 | 0.199 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.328112e-01 | 0.199 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.328112e-01 | 0.199 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.328112e-01 | 0.199 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.337808e-01 | 0.198 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.337808e-01 | 0.198 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.337808e-01 | 0.198 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.337808e-01 | 0.198 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.393808e-01 | 0.194 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.393808e-01 | 0.194 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.403244e-01 | 0.194 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.413739e-01 | 0.193 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.413739e-01 | 0.193 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.416230e-01 | 0.193 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.416230e-01 | 0.193 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.459607e-01 | 0.190 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.459607e-01 | 0.190 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.459607e-01 | 0.190 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.469940e-01 | 0.189 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.548903e-01 | 0.184 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.548903e-01 | 0.184 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.548903e-01 | 0.184 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.548903e-01 | 0.184 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.548903e-01 | 0.184 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.548903e-01 | 0.184 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.548903e-01 | 0.184 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.570140e-01 | 0.182 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.570140e-01 | 0.182 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.570140e-01 | 0.182 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.570140e-01 | 0.182 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.570140e-01 | 0.182 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.570140e-01 | 0.182 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.570140e-01 | 0.182 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.570140e-01 | 0.182 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.570140e-01 | 0.182 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.570140e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.570140e-01 | 0.182 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.570140e-01 | 0.182 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.571217e-01 | 0.182 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.571217e-01 | 0.182 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 6.571217e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.586424e-01 | 0.181 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.609988e-01 | 0.180 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.655739e-01 | 0.177 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.655739e-01 | 0.177 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.666279e-01 | 0.176 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.692553e-01 | 0.174 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.737384e-01 | 0.172 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.739401e-01 | 0.171 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.750373e-01 | 0.171 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.750373e-01 | 0.171 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.750373e-01 | 0.171 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.750373e-01 | 0.171 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.750373e-01 | 0.171 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.750373e-01 | 0.171 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.750373e-01 | 0.171 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.750373e-01 | 0.171 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.750373e-01 | 0.171 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.750373e-01 | 0.171 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.750373e-01 | 0.171 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.750373e-01 | 0.171 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.750373e-01 | 0.171 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.750373e-01 | 0.171 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.750373e-01 | 0.171 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.750373e-01 | 0.171 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.750373e-01 | 0.171 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.750373e-01 | 0.171 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.750373e-01 | 0.171 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.750373e-01 | 0.171 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.750373e-01 | 0.171 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.750373e-01 | 0.171 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.750373e-01 | 0.171 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.750373e-01 | 0.171 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.750373e-01 | 0.171 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.750373e-01 | 0.171 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.754106e-01 | 0.170 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.780408e-01 | 0.169 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.793728e-01 | 0.168 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.803225e-01 | 0.167 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.803225e-01 | 0.167 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.803225e-01 | 0.167 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.815293e-01 | 0.167 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.815293e-01 | 0.167 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.815400e-01 | 0.167 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.815400e-01 | 0.167 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.815400e-01 | 0.167 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.815400e-01 | 0.167 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.815400e-01 | 0.167 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.817590e-01 | 0.166 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.817590e-01 | 0.166 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.817590e-01 | 0.166 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.817590e-01 | 0.166 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.837469e-01 | 0.165 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.844872e-01 | 0.165 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.844872e-01 | 0.165 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.855529e-01 | 0.164 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.878932e-01 | 0.162 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.878932e-01 | 0.162 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.886262e-01 | 0.162 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.890983e-01 | 0.162 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.890983e-01 | 0.162 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.890983e-01 | 0.162 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.890983e-01 | 0.162 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.890983e-01 | 0.162 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.890983e-01 | 0.162 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.890983e-01 | 0.162 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.890983e-01 | 0.162 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.890983e-01 | 0.162 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.918357e-01 | 0.160 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.941023e-01 | 0.159 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.024011e-01 | 0.153 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.024011e-01 | 0.153 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.024011e-01 | 0.153 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.024011e-01 | 0.153 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.024011e-01 | 0.153 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.026867e-01 | 0.153 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.026867e-01 | 0.153 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.026867e-01 | 0.153 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.047394e-01 | 0.152 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.061120e-01 | 0.151 | 1 | 1 |
| Chromosome Maintenance | R-HSA-73886 | 7.061120e-01 | 0.151 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.066261e-01 | 0.151 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.066261e-01 | 0.151 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.066261e-01 | 0.151 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.066261e-01 | 0.151 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.066261e-01 | 0.151 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.066261e-01 | 0.151 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.073933e-01 | 0.150 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.136358e-01 | 0.147 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.176449e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.176449e-01 | 0.144 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.176449e-01 | 0.144 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.176449e-01 | 0.144 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.176449e-01 | 0.144 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.176449e-01 | 0.144 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.176449e-01 | 0.144 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.176449e-01 | 0.144 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.176449e-01 | 0.144 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.176449e-01 | 0.144 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.186682e-01 | 0.143 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.186682e-01 | 0.143 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.186682e-01 | 0.143 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.186682e-01 | 0.143 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.186682e-01 | 0.143 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.186682e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.186682e-01 | 0.143 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.186682e-01 | 0.143 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.186682e-01 | 0.143 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.201635e-01 | 0.143 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.225890e-01 | 0.141 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.225890e-01 | 0.141 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.231135e-01 | 0.141 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.233071e-01 | 0.141 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.301675e-01 | 0.137 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.301675e-01 | 0.137 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.301675e-01 | 0.137 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.349191e-01 | 0.134 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.357296e-01 | 0.133 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.365868e-01 | 0.133 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.365868e-01 | 0.133 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.369133e-01 | 0.133 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.369133e-01 | 0.133 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.369133e-01 | 0.133 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.372463e-01 | 0.132 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.424060e-01 | 0.129 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.458312e-01 | 0.127 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.458312e-01 | 0.127 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.458312e-01 | 0.127 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.458312e-01 | 0.127 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.458312e-01 | 0.127 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.458312e-01 | 0.127 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.458312e-01 | 0.127 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.458312e-01 | 0.127 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.458312e-01 | 0.127 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.458312e-01 | 0.127 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.458312e-01 | 0.127 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.458312e-01 | 0.127 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.458312e-01 | 0.127 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.471556e-01 | 0.127 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.511500e-01 | 0.124 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.513785e-01 | 0.124 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.515807e-01 | 0.124 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.521962e-01 | 0.124 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.521962e-01 | 0.124 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.529358e-01 | 0.123 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.529358e-01 | 0.123 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.539942e-01 | 0.123 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.546682e-01 | 0.122 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.546682e-01 | 0.122 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.546682e-01 | 0.122 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.546682e-01 | 0.122 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.546682e-01 | 0.122 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.546682e-01 | 0.122 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.546682e-01 | 0.122 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.546682e-01 | 0.122 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.546682e-01 | 0.122 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.546682e-01 | 0.122 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.546682e-01 | 0.122 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.546682e-01 | 0.122 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.546682e-01 | 0.122 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.546682e-01 | 0.122 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.546682e-01 | 0.122 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.560279e-01 | 0.121 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.562741e-01 | 0.121 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.577385e-01 | 0.120 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.582495e-01 | 0.120 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.603763e-01 | 0.119 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.619274e-01 | 0.118 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.619274e-01 | 0.118 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.647937e-01 | 0.116 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.682349e-01 | 0.115 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.682349e-01 | 0.115 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.707101e-01 | 0.113 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.707101e-01 | 0.113 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.707101e-01 | 0.113 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.707101e-01 | 0.113 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.707101e-01 | 0.113 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.707101e-01 | 0.113 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.707101e-01 | 0.113 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.727547e-01 | 0.112 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.766161e-01 | 0.110 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.771885e-01 | 0.109 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.771885e-01 | 0.109 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.795809e-01 | 0.108 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.795809e-01 | 0.108 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.828174e-01 | 0.106 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.868387e-01 | 0.104 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.868387e-01 | 0.104 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.868387e-01 | 0.104 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.868387e-01 | 0.104 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.868387e-01 | 0.104 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.868387e-01 | 0.104 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.868387e-01 | 0.104 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.868387e-01 | 0.104 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.868387e-01 | 0.104 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.868387e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.868387e-01 | 0.104 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.868387e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.879333e-01 | 0.104 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.879333e-01 | 0.104 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.879333e-01 | 0.104 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.891052e-01 | 0.103 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.904708e-01 | 0.102 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.916711e-01 | 0.101 | 1 | 1 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.916711e-01 | 0.101 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.918938e-01 | 0.101 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.918938e-01 | 0.101 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.918938e-01 | 0.101 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.928622e-01 | 0.101 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.934368e-01 | 0.100 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.934368e-01 | 0.100 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.934368e-01 | 0.100 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.934368e-01 | 0.100 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.934368e-01 | 0.100 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.934368e-01 | 0.100 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.964676e-01 | 0.099 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.966935e-01 | 0.099 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.026212e-01 | 0.095 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.096703e-01 | 0.092 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.096703e-01 | 0.092 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.117559e-01 | 0.091 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.141478e-01 | 0.089 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.141478e-01 | 0.089 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.141478e-01 | 0.089 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.147922e-01 | 0.089 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.147922e-01 | 0.089 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.147922e-01 | 0.089 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.147922e-01 | 0.089 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.147922e-01 | 0.089 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.147922e-01 | 0.089 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.147922e-01 | 0.089 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.164921e-01 | 0.088 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.164921e-01 | 0.088 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.164921e-01 | 0.088 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.164921e-01 | 0.088 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.173648e-01 | 0.088 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.220325e-01 | 0.085 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.261457e-01 | 0.083 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.263435e-01 | 0.083 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.263435e-01 | 0.083 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.263435e-01 | 0.083 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.263435e-01 | 0.083 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.272036e-01 | 0.082 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.278025e-01 | 0.082 | 1 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.287408e-01 | 0.082 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.329809e-01 | 0.079 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.329809e-01 | 0.079 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.329809e-01 | 0.079 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.329809e-01 | 0.079 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.329809e-01 | 0.079 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.329809e-01 | 0.079 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.359260e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.359260e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.359260e-01 | 0.078 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.390814e-01 | 0.076 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.390814e-01 | 0.076 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.390814e-01 | 0.076 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.390814e-01 | 0.076 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.390814e-01 | 0.076 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.390814e-01 | 0.076 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.390814e-01 | 0.076 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.390814e-01 | 0.076 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.390814e-01 | 0.076 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.390814e-01 | 0.076 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.390814e-01 | 0.076 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.390814e-01 | 0.076 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.413841e-01 | 0.075 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.413841e-01 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.413841e-01 | 0.075 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.413841e-01 | 0.075 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.417458e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.418773e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.425392e-01 | 0.074 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.500722e-01 | 0.071 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.500722e-01 | 0.071 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.500722e-01 | 0.071 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.500722e-01 | 0.071 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.527063e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.527063e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.527063e-01 | 0.069 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.534437e-01 | 0.069 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.554518e-01 | 0.068 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.554518e-01 | 0.068 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.566896e-01 | 0.067 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.566896e-01 | 0.067 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.566896e-01 | 0.067 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.585481e-01 | 0.066 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.595303e-01 | 0.066 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.601864e-01 | 0.065 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.601864e-01 | 0.065 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.601864e-01 | 0.065 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.601864e-01 | 0.065 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.601864e-01 | 0.065 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.601864e-01 | 0.065 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.601864e-01 | 0.065 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.601864e-01 | 0.065 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.601864e-01 | 0.065 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.620793e-01 | 0.064 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.636016e-01 | 0.064 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.636016e-01 | 0.064 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.642966e-01 | 0.063 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.642966e-01 | 0.063 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.642966e-01 | 0.063 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.645622e-01 | 0.063 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.645622e-01 | 0.063 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.655547e-01 | 0.063 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.655547e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.655547e-01 | 0.063 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.655547e-01 | 0.063 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.655547e-01 | 0.063 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.655547e-01 | 0.063 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.657711e-01 | 0.063 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.679481e-01 | 0.062 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.682190e-01 | 0.061 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.684153e-01 | 0.061 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.684153e-01 | 0.061 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.727001e-01 | 0.059 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.744650e-01 | 0.058 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.753589e-01 | 0.058 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.753589e-01 | 0.058 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.754875e-01 | 0.058 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.755899e-01 | 0.058 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.755899e-01 | 0.058 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.755899e-01 | 0.058 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.785245e-01 | 0.056 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.785245e-01 | 0.056 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.785245e-01 | 0.056 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.785245e-01 | 0.056 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.785245e-01 | 0.056 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.785245e-01 | 0.056 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.795563e-01 | 0.056 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.795563e-01 | 0.056 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.795563e-01 | 0.056 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.803412e-01 | 0.055 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.803412e-01 | 0.055 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.803412e-01 | 0.055 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.803412e-01 | 0.055 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.811936e-01 | 0.055 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.817445e-01 | 0.055 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.834076e-01 | 0.054 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.839788e-01 | 0.054 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.841927e-01 | 0.053 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.858317e-01 | 0.053 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.858317e-01 | 0.053 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.858317e-01 | 0.053 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.878206e-01 | 0.052 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.878206e-01 | 0.052 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.897041e-01 | 0.051 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.899592e-01 | 0.051 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.899592e-01 | 0.051 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.905607e-01 | 0.050 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.912950e-01 | 0.050 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.912950e-01 | 0.050 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.912950e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.917902e-01 | 0.050 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.921990e-01 | 0.050 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.921990e-01 | 0.050 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.921990e-01 | 0.050 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.928681e-01 | 0.049 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.944583e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.944583e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.944583e-01 | 0.048 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.944583e-01 | 0.048 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.944583e-01 | 0.048 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.944583e-01 | 0.048 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.944583e-01 | 0.048 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.944583e-01 | 0.048 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.944583e-01 | 0.048 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.944583e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.944583e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.944583e-01 | 0.048 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.953298e-01 | 0.048 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.953298e-01 | 0.048 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.956237e-01 | 0.048 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.997179e-01 | 0.046 | 1 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.002770e-01 | 0.046 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.011629e-01 | 0.045 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.012655e-01 | 0.045 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.013408e-01 | 0.045 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.019605e-01 | 0.045 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.035984e-01 | 0.044 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.035984e-01 | 0.044 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.037762e-01 | 0.044 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.041258e-01 | 0.044 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.055490e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.064181e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.064181e-01 | 0.043 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.068980e-01 | 0.042 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.075675e-01 | 0.042 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.083028e-01 | 0.042 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.083028e-01 | 0.042 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.083028e-01 | 0.042 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.083028e-01 | 0.042 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.083028e-01 | 0.042 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.083028e-01 | 0.042 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.083028e-01 | 0.042 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.083028e-01 | 0.042 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.083028e-01 | 0.042 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.083028e-01 | 0.042 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.083028e-01 | 0.042 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.084266e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.088933e-01 | 0.041 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.090627e-01 | 0.041 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.102684e-01 | 0.041 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.105406e-01 | 0.041 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.105406e-01 | 0.041 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.105406e-01 | 0.041 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.122607e-01 | 0.040 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.122607e-01 | 0.040 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.138370e-01 | 0.039 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.138629e-01 | 0.039 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.144039e-01 | 0.039 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.144039e-01 | 0.039 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.144039e-01 | 0.039 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.145261e-01 | 0.039 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.145261e-01 | 0.039 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.160889e-01 | 0.038 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.171284e-01 | 0.038 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.189136e-01 | 0.037 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.189543e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.189543e-01 | 0.037 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.197747e-01 | 0.036 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.197747e-01 | 0.036 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.203320e-01 | 0.036 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.203320e-01 | 0.036 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.203320e-01 | 0.036 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.203320e-01 | 0.036 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.203320e-01 | 0.036 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.203320e-01 | 0.036 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.203320e-01 | 0.036 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.203320e-01 | 0.036 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.203320e-01 | 0.036 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.203320e-01 | 0.036 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.203320e-01 | 0.036 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.203320e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.203320e-01 | 0.036 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.207906e-01 | 0.036 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.207906e-01 | 0.036 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.227788e-01 | 0.035 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.227788e-01 | 0.035 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.230942e-01 | 0.035 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.230942e-01 | 0.035 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.230942e-01 | 0.035 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.230942e-01 | 0.035 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.246000e-01 | 0.034 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.256864e-01 | 0.034 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.257840e-01 | 0.033 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.266390e-01 | 0.033 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.266390e-01 | 0.033 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.266390e-01 | 0.033 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.267064e-01 | 0.033 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.267561e-01 | 0.033 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.267561e-01 | 0.033 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.267561e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.282355e-01 | 0.032 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.289915e-01 | 0.032 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.289915e-01 | 0.032 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.289915e-01 | 0.032 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.307837e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.307837e-01 | 0.031 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.307837e-01 | 0.031 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.307837e-01 | 0.031 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.307837e-01 | 0.031 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.307837e-01 | 0.031 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.307837e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.307837e-01 | 0.031 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.313866e-01 | 0.031 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.313866e-01 | 0.031 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.313866e-01 | 0.031 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.313866e-01 | 0.031 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.317663e-01 | 0.031 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.330935e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.336494e-01 | 0.030 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.336494e-01 | 0.030 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.347547e-01 | 0.029 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.350682e-01 | 0.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.356200e-01 | 0.029 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.388275e-01 | 0.027 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.389720e-01 | 0.027 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.389720e-01 | 0.027 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.398648e-01 | 0.027 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.398648e-01 | 0.027 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.398648e-01 | 0.027 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.398648e-01 | 0.027 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.398648e-01 | 0.027 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.398648e-01 | 0.027 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.398648e-01 | 0.027 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.398648e-01 | 0.027 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.398648e-01 | 0.027 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.398648e-01 | 0.027 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.398648e-01 | 0.027 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.398648e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.398648e-01 | 0.027 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.400371e-01 | 0.027 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.400371e-01 | 0.027 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.400371e-01 | 0.027 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.400951e-01 | 0.027 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.400951e-01 | 0.027 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.407862e-01 | 0.027 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.442682e-01 | 0.025 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.443765e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.443765e-01 | 0.025 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.453136e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.454976e-01 | 0.024 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.454976e-01 | 0.024 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.454976e-01 | 0.024 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.477550e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.477550e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.477550e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.477550e-01 | 0.023 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.477550e-01 | 0.023 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.477550e-01 | 0.023 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.477805e-01 | 0.023 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.478314e-01 | 0.023 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.492322e-01 | 0.023 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.493399e-01 | 0.023 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.504043e-01 | 0.022 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.509253e-01 | 0.022 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.514710e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.514710e-01 | 0.022 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.519356e-01 | 0.021 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.538937e-01 | 0.021 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.538937e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.543300e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.546102e-01 | 0.020 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.546102e-01 | 0.020 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.546102e-01 | 0.020 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.546102e-01 | 0.020 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.559376e-01 | 0.020 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.559376e-01 | 0.020 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.568156e-01 | 0.019 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.568156e-01 | 0.019 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.568156e-01 | 0.019 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.568156e-01 | 0.019 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.568156e-01 | 0.019 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.568156e-01 | 0.019 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.585622e-01 | 0.018 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.586190e-01 | 0.018 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.600567e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.602939e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.602939e-01 | 0.018 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.602939e-01 | 0.018 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.605664e-01 | 0.017 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.605664e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.605664e-01 | 0.017 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.605664e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.605664e-01 | 0.017 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.605664e-01 | 0.017 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.613276e-01 | 0.017 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.615936e-01 | 0.017 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.618293e-01 | 0.017 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.642430e-01 | 0.016 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.642430e-01 | 0.016 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.653859e-01 | 0.015 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.657412e-01 | 0.015 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.657412e-01 | 0.015 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.657412e-01 | 0.015 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.657412e-01 | 0.015 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.657412e-01 | 0.015 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.671040e-01 | 0.015 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.676889e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.678197e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.678197e-01 | 0.014 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.685818e-01 | 0.014 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.695607e-01 | 0.013 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.702372e-01 | 0.013 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.702372e-01 | 0.013 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.702372e-01 | 0.013 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.702372e-01 | 0.013 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.702372e-01 | 0.013 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.702372e-01 | 0.013 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.704234e-01 | 0.013 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.710565e-01 | 0.013 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.710565e-01 | 0.013 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.729570e-01 | 0.012 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.739800e-01 | 0.011 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.741434e-01 | 0.011 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.741434e-01 | 0.011 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.741434e-01 | 0.011 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.741434e-01 | 0.011 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.741638e-01 | 0.011 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.744872e-01 | 0.011 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.749535e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.754376e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.755954e-01 | 0.011 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.756559e-01 | 0.011 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.759622e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.759622e-01 | 0.011 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.760979e-01 | 0.011 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.766273e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.775372e-01 | 0.010 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.775372e-01 | 0.010 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.775372e-01 | 0.010 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.775372e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.776094e-01 | 0.010 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.787957e-01 | 0.009 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.787957e-01 | 0.009 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.787957e-01 | 0.009 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.787957e-01 | 0.009 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.788044e-01 | 0.009 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.788044e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.790144e-01 | 0.009 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.790144e-01 | 0.009 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.795517e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.796008e-01 | 0.009 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.804784e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.804856e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.804856e-01 | 0.009 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.804856e-01 | 0.009 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.804856e-01 | 0.009 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.804856e-01 | 0.009 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.804856e-01 | 0.009 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.804856e-01 | 0.009 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.804856e-01 | 0.009 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.808185e-01 | 0.008 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.808393e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.808900e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.811679e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.825173e-01 | 0.008 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.826507e-01 | 0.008 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.830472e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.830472e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.830472e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.830472e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.830472e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.830472e-01 | 0.007 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.830472e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.830472e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.830472e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.830472e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.831092e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.831964e-01 | 0.007 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.840144e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.843163e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.843163e-01 | 0.007 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.844605e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.851602e-01 | 0.006 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.852338e-01 | 0.006 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.852338e-01 | 0.006 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.852338e-01 | 0.006 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.852338e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.852338e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.852338e-01 | 0.006 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.852727e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.852727e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.852727e-01 | 0.006 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.852727e-01 | 0.006 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.852727e-01 | 0.006 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.852727e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.852727e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.852727e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.852864e-01 | 0.006 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.853908e-01 | 0.006 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.854774e-01 | 0.006 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.858574e-01 | 0.006 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.864325e-01 | 0.006 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.864325e-01 | 0.006 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.866174e-01 | 0.006 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.871362e-01 | 0.006 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.872030e-01 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.872030e-01 | 0.006 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.872061e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.872061e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.872061e-01 | 0.006 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.872061e-01 | 0.006 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.876243e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.888858e-01 | 0.005 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.888858e-01 | 0.005 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.888858e-01 | 0.005 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.888858e-01 | 0.005 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.891228e-01 | 0.005 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.897534e-01 | 0.004 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.897534e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.897534e-01 | 0.004 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.902674e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.903451e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.903451e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.903451e-01 | 0.004 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.903451e-01 | 0.004 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.904997e-01 | 0.004 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.904997e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.904997e-01 | 0.004 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.907553e-01 | 0.004 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.909349e-01 | 0.004 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.909349e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.912953e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.916128e-01 | 0.004 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.919829e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.922500e-01 | 0.003 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.927009e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.927142e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.929121e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.929238e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.931284e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.935869e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.935869e-01 | 0.003 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.936710e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.937355e-01 | 0.003 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.944285e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.944532e-01 | 0.002 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.944650e-01 | 0.002 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.945021e-01 | 0.002 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.945021e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.945021e-01 | 0.002 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.949946e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.949946e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.949946e-01 | 0.002 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.951109e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.951109e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.952242e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.955001e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.955001e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.956582e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.957068e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.958515e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.960594e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.960600e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.961265e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.961887e-01 | 0.002 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.962689e-01 | 0.002 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.963964e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.963964e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.964871e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.964871e-01 | 0.002 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.967796e-01 | 0.001 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.968698e-01 | 0.001 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.968698e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.968698e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.970321e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.970321e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.970802e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.971424e-01 | 0.001 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.972810e-01 | 0.001 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.972810e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.972810e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.972810e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.973123e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.973123e-01 | 0.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.976025e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.976382e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.976382e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.979485e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.979485e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.979485e-01 | 0.001 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.979643e-01 | 0.001 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.981227e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.982008e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.982180e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.982474e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.984409e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.984522e-01 | 0.001 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.984522e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.984522e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.986067e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.986556e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.988322e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.988322e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.988721e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.989857e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.990282e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.991190e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.991463e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992318e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.992348e-01 | 0.000 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.992348e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.992624e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.992624e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.993023e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.993354e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993354e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.993424e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.993886e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.994093e-01 | 0.000 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.994227e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.994430e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.994680e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.994680e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.994680e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.994975e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.995025e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.995232e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.996218e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.996487e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997147e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997147e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997151e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997359e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.997489e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997522e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.997522e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997692e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.997871e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.998010e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998208e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998405e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998426e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998426e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998431e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998431e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998629e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998776e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.998937e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999198e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999279e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999304e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999367e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999395e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999544e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999593e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999604e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999604e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999604e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999632e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999632e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999654e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999656e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999684e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999706e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999712e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999736e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999741e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999790e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999822e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999830e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999846e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999853e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999853e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999889e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999889e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999903e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999936e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999945e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999949e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999956e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999964e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999973e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999976e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999988e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999989e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999990e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999991e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999995e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999995e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 1 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 3.280964e-11 | 10.484 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.827872e-10 | 9.738 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.704225e-10 | 9.568 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.967754e-10 | 9.224 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.026363e-08 | 7.693 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.915595e-08 | 7.718 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.582097e-08 | 7.253 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.725035e-07 | 6.763 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.407087e-06 | 5.852 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.288251e-06 | 5.137 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.438427e-06 | 5.025 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.488050e-05 | 4.071 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.417622e-05 | 4.026 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.032702e-04 | 3.986 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.013842e-04 | 3.994 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.237753e-04 | 3.907 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.344428e-04 | 3.871 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.344428e-04 | 3.871 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.555590e-04 | 3.808 | 1 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.701765e-04 | 3.769 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.874216e-04 | 3.727 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.264620e-04 | 3.645 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.706099e-04 | 3.568 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.160042e-04 | 3.500 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.069935e-04 | 3.513 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.556689e-04 | 3.449 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.098690e-04 | 3.387 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.447936e-04 | 3.073 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.279324e-04 | 3.082 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.037316e-03 | 2.984 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.037316e-03 | 2.984 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.424113e-04 | 3.026 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.014256e-03 | 2.994 | 1 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.046448e-03 | 2.980 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.062174e-03 | 2.974 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.215202e-03 | 2.915 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.243946e-03 | 2.905 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.318772e-03 | 2.880 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.354208e-03 | 2.868 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.376330e-03 | 2.861 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.440745e-03 | 2.841 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.414630e-03 | 2.849 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.623900e-03 | 2.789 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.623615e-03 | 2.790 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.703538e-03 | 2.769 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.786739e-03 | 2.748 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.750321e-03 | 2.757 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.870090e-03 | 2.728 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.816718e-03 | 2.741 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.146636e-03 | 2.668 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.034677e-03 | 2.692 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.173724e-03 | 2.663 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.064125e-03 | 2.685 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.186170e-03 | 2.660 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.303642e-03 | 2.638 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.488282e-03 | 2.604 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.564106e-03 | 2.591 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.157770e-03 | 2.501 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.139382e-03 | 2.503 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.754796e-03 | 2.560 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.045789e-03 | 2.516 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.157770e-03 | 2.501 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.904524e-03 | 2.537 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.443890e-03 | 2.463 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.443890e-03 | 2.463 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.516713e-03 | 2.454 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.598559e-03 | 2.444 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.003882e-03 | 2.398 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.003882e-03 | 2.398 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.301072e-03 | 2.366 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.326748e-03 | 2.364 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.776186e-03 | 2.321 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.674656e-03 | 2.330 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.674656e-03 | 2.330 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.004898e-03 | 2.301 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.902933e-03 | 2.310 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.923538e-03 | 2.308 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.936848e-03 | 2.307 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.773089e-03 | 2.321 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.246534e-03 | 2.280 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.246534e-03 | 2.280 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.328944e-03 | 2.273 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.103326e-03 | 2.214 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.127034e-03 | 2.213 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.103326e-03 | 2.214 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.221046e-03 | 2.206 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.248872e-03 | 2.204 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.359155e-03 | 2.197 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.677303e-03 | 2.175 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.677303e-03 | 2.175 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.677303e-03 | 2.175 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.677303e-03 | 2.175 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.677303e-03 | 2.175 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.693907e-03 | 2.174 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.922985e-03 | 2.160 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.329098e-03 | 2.135 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.240373e-03 | 2.140 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.457281e-03 | 2.127 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.143346e-03 | 2.146 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.703906e-03 | 2.113 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.821550e-03 | 2.107 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.871386e-03 | 2.104 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.902370e-03 | 2.102 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.941149e-03 | 2.100 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.976566e-03 | 2.098 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.357559e-03 | 2.078 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.357559e-03 | 2.078 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.790492e-03 | 2.056 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.589788e-03 | 2.018 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.589788e-03 | 2.018 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.589788e-03 | 2.018 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.589788e-03 | 2.018 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.247396e-03 | 2.034 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.026111e-02 | 1.989 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.043610e-02 | 1.981 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.043610e-02 | 1.981 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.046004e-02 | 1.980 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.065228e-02 | 1.973 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.150413e-02 | 1.939 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.100623e-02 | 1.958 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.155512e-02 | 1.937 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.188296e-02 | 1.925 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.093542e-02 | 1.961 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.196768e-02 | 1.922 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.201605e-02 | 1.920 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.234893e-02 | 1.908 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.234893e-02 | 1.908 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.329025e-02 | 1.876 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.329025e-02 | 1.876 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.488850e-02 | 1.827 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.481389e-02 | 1.829 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.462823e-02 | 1.835 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.500528e-02 | 1.824 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.524677e-02 | 1.817 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.636654e-02 | 1.786 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.696099e-02 | 1.771 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.732442e-02 | 1.761 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.749938e-02 | 1.757 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.803863e-02 | 1.744 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.778166e-02 | 1.750 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.803863e-02 | 1.744 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.968597e-02 | 1.706 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.981219e-02 | 1.703 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.036709e-02 | 1.691 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.042887e-02 | 1.690 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.042887e-02 | 1.690 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.129896e-02 | 1.672 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.151619e-02 | 1.667 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.380251e-02 | 1.623 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.380251e-02 | 1.623 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.420727e-02 | 1.616 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.420727e-02 | 1.616 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.241221e-02 | 1.650 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.272866e-02 | 1.643 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.272866e-02 | 1.643 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.352501e-02 | 1.628 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.312243e-02 | 1.636 | 1 | 1 |
| G0 and Early G1 | R-HSA-1538133 | 2.369616e-02 | 1.625 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.272267e-02 | 1.644 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.401429e-02 | 1.620 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.424498e-02 | 1.615 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.441642e-02 | 1.612 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.457801e-02 | 1.609 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.538172e-02 | 1.595 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.594375e-02 | 1.586 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.598969e-02 | 1.585 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.619104e-02 | 1.582 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.731951e-02 | 1.564 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.749208e-02 | 1.561 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.768202e-02 | 1.558 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.768202e-02 | 1.558 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.768202e-02 | 1.558 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.830004e-02 | 1.548 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.852004e-02 | 1.545 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.871900e-02 | 1.542 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.871900e-02 | 1.542 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.209903e-02 | 1.494 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.069540e-02 | 1.513 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.131607e-02 | 1.504 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.947196e-02 | 1.531 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.244223e-02 | 1.489 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.131607e-02 | 1.504 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.332695e-02 | 1.477 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.226869e-02 | 1.491 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.332695e-02 | 1.477 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.131607e-02 | 1.504 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.929871e-02 | 1.533 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.333762e-02 | 1.477 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.333762e-02 | 1.477 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.333762e-02 | 1.477 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.369992e-02 | 1.472 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.485523e-02 | 1.458 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.508864e-02 | 1.455 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.525666e-02 | 1.453 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.570172e-02 | 1.447 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.752148e-02 | 1.426 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.752148e-02 | 1.426 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.068201e-02 | 1.391 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.068201e-02 | 1.391 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.188940e-02 | 1.378 | 1 | 1 |
| Gap junction degradation | R-HSA-190873 | 4.188940e-02 | 1.378 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.783904e-02 | 1.422 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.333097e-02 | 1.363 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.333097e-02 | 1.363 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.049089e-02 | 1.393 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.867951e-02 | 1.413 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.905162e-02 | 1.408 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.879398e-02 | 1.411 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.354138e-02 | 1.361 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.289336e-02 | 1.368 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.990009e-02 | 1.399 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.196083e-02 | 1.377 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.188940e-02 | 1.378 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.168094e-02 | 1.380 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.972639e-02 | 1.401 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.817952e-02 | 1.418 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.408068e-02 | 1.356 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.827570e-02 | 1.417 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.990009e-02 | 1.399 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.575565e-02 | 1.340 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.575565e-02 | 1.340 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.603976e-02 | 1.337 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.668654e-02 | 1.331 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.711040e-02 | 1.327 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.742348e-02 | 1.324 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.774017e-02 | 1.321 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.907565e-02 | 1.309 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.932399e-02 | 1.307 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.996534e-02 | 1.301 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.114646e-02 | 1.291 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.114646e-02 | 1.291 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.225362e-02 | 1.282 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.318303e-02 | 1.274 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.318303e-02 | 1.274 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.409434e-02 | 1.267 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.423020e-02 | 1.192 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.423020e-02 | 1.192 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.285627e-02 | 1.202 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.285627e-02 | 1.202 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.331040e-02 | 1.199 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.697343e-02 | 1.244 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.260707e-02 | 1.203 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.027017e-02 | 1.220 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.423020e-02 | 1.192 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.331040e-02 | 1.199 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.915541e-02 | 1.228 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.524615e-02 | 1.185 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.969516e-02 | 1.224 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.572557e-02 | 1.254 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.572557e-02 | 1.254 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.913405e-02 | 1.228 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.596252e-02 | 1.181 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.681390e-02 | 1.175 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.681390e-02 | 1.175 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.681390e-02 | 1.175 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.773187e-02 | 1.169 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.898431e-02 | 1.161 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.960823e-02 | 1.157 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.039034e-02 | 1.152 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.087855e-02 | 1.149 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.192942e-02 | 1.143 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.210261e-02 | 1.142 | 1 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.355156e-02 | 1.133 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.357558e-02 | 1.133 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.391644e-02 | 1.131 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.391644e-02 | 1.131 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.391644e-02 | 1.131 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.391644e-02 | 1.131 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.416430e-02 | 1.130 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.429069e-02 | 1.026 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.429069e-02 | 1.026 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.429069e-02 | 1.026 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.429069e-02 | 1.026 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.104744e-02 | 1.041 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.616934e-02 | 1.065 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.616934e-02 | 1.065 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.616934e-02 | 1.065 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.620694e-02 | 1.064 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.620694e-02 | 1.064 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.710950e-02 | 1.060 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.787591e-02 | 1.109 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.988601e-02 | 1.098 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.651675e-02 | 1.116 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.168994e-02 | 1.038 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.018690e-02 | 1.096 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.620694e-02 | 1.064 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.973325e-02 | 1.098 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.804167e-02 | 1.055 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.207169e-02 | 1.036 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.207169e-02 | 1.036 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.339936e-02 | 1.079 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.668286e-02 | 1.115 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.210540e-02 | 1.086 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.188175e-02 | 1.087 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.653778e-02 | 1.116 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.829645e-02 | 1.106 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.925086e-02 | 1.049 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.018690e-02 | 1.096 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.582350e-02 | 1.120 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.842714e-02 | 1.053 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.842639e-02 | 1.106 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.324654e-02 | 1.030 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.438851e-02 | 1.074 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.449670e-02 | 1.025 | 1 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.579483e-02 | 1.019 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 9.579483e-02 | 1.019 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.625270e-02 | 1.017 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.625270e-02 | 1.017 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.689093e-02 | 1.014 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.689093e-02 | 1.014 | 1 | 1 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.690491e-02 | 1.014 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.754695e-02 | 1.011 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.762724e-02 | 1.010 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.000934e-01 | 1.000 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.015572e-01 | 0.993 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.018109e-01 | 0.992 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.018109e-01 | 0.992 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.018109e-01 | 0.992 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.018109e-01 | 0.992 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.018109e-01 | 0.992 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.018109e-01 | 0.992 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.018109e-01 | 0.992 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.018109e-01 | 0.992 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.018109e-01 | 0.992 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.018109e-01 | 0.992 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.018109e-01 | 0.992 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.018109e-01 | 0.992 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.018109e-01 | 0.992 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.018109e-01 | 0.992 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.018109e-01 | 0.992 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.018109e-01 | 0.992 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.018109e-01 | 0.992 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.021426e-01 | 0.991 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.023424e-01 | 0.990 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.032760e-01 | 0.986 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.032760e-01 | 0.986 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.366464e-01 | 0.864 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.366464e-01 | 0.864 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.366464e-01 | 0.864 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.366464e-01 | 0.864 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.163770e-01 | 0.934 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.163770e-01 | 0.934 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.163770e-01 | 0.934 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.163770e-01 | 0.934 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.127080e-01 | 0.948 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.308344e-01 | 0.883 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.203810e-01 | 0.919 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.338297e-01 | 0.873 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.379642e-01 | 0.860 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.221705e-01 | 0.913 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.075306e-01 | 0.968 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.295758e-01 | 0.887 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.316821e-01 | 0.880 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.330522e-01 | 0.876 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.208178e-01 | 0.918 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.341929e-01 | 0.872 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.265101e-01 | 0.898 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.136357e-01 | 0.944 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.189412e-01 | 0.925 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.076404e-01 | 0.968 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.327406e-01 | 0.877 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.366464e-01 | 0.864 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.366464e-01 | 0.864 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.163770e-01 | 0.934 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.308344e-01 | 0.883 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.208178e-01 | 0.918 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.208178e-01 | 0.918 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.208178e-01 | 0.918 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.208178e-01 | 0.918 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.204678e-01 | 0.919 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.308344e-01 | 0.883 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.062145e-01 | 0.974 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.142364e-01 | 0.942 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.338702e-01 | 0.873 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.142364e-01 | 0.942 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.238571e-01 | 0.907 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.354583e-01 | 0.868 | 1 | 1 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.208178e-01 | 0.918 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.238571e-01 | 0.907 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.308344e-01 | 0.883 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.221705e-01 | 0.913 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.295758e-01 | 0.887 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.078975e-01 | 0.967 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.078975e-01 | 0.967 | 1 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.308344e-01 | 0.883 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.127080e-01 | 0.948 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.250562e-01 | 0.903 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.271078e-01 | 0.896 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.309990e-01 | 0.883 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.308344e-01 | 0.883 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.308586e-01 | 0.883 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.208178e-01 | 0.918 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.187832e-01 | 0.925 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.366464e-01 | 0.864 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.127080e-01 | 0.948 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.386710e-01 | 0.858 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.386710e-01 | 0.858 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.401765e-01 | 0.853 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.401765e-01 | 0.853 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.401765e-01 | 0.853 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.403463e-01 | 0.853 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.413251e-01 | 0.850 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.414641e-01 | 0.849 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.427937e-01 | 0.845 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.433451e-01 | 0.844 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.460243e-01 | 0.836 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.489681e-01 | 0.827 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.493090e-01 | 0.826 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.499313e-01 | 0.824 | 1 | 1 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.500714e-01 | 0.824 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.500714e-01 | 0.824 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.500714e-01 | 0.824 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.500714e-01 | 0.824 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.509657e-01 | 0.821 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.537270e-01 | 0.813 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.559651e-01 | 0.807 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.562204e-01 | 0.806 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.563280e-01 | 0.806 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.563776e-01 | 0.806 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.563776e-01 | 0.806 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.585641e-01 | 0.800 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.585641e-01 | 0.800 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.586829e-01 | 0.799 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.932617e-01 | 0.714 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.932617e-01 | 0.714 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.932617e-01 | 0.714 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.932617e-01 | 0.714 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.932617e-01 | 0.714 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.932617e-01 | 0.714 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.932617e-01 | 0.714 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.932617e-01 | 0.714 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.754061e-01 | 0.560 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.754061e-01 | 0.560 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.754061e-01 | 0.560 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.754061e-01 | 0.560 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.754061e-01 | 0.560 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.754061e-01 | 0.560 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.754061e-01 | 0.560 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.754061e-01 | 0.560 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.754061e-01 | 0.560 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.739060e-01 | 0.760 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.739060e-01 | 0.760 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 1.739060e-01 | 0.760 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.739060e-01 | 0.760 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.125311e-01 | 0.673 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.125311e-01 | 0.673 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.125311e-01 | 0.673 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.125311e-01 | 0.673 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.491907e-01 | 0.457 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.491907e-01 | 0.457 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.491907e-01 | 0.457 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.491907e-01 | 0.457 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.491907e-01 | 0.457 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.491907e-01 | 0.457 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.491907e-01 | 0.457 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.654358e-01 | 0.781 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.654358e-01 | 0.781 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.518578e-01 | 0.599 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.518578e-01 | 0.599 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.518578e-01 | 0.599 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.919021e-01 | 0.717 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.703085e-01 | 0.769 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.193295e-01 | 0.659 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.193295e-01 | 0.659 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.913433e-01 | 0.536 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.913433e-01 | 0.536 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.913433e-01 | 0.536 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.913433e-01 | 0.536 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.913433e-01 | 0.536 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.913433e-01 | 0.536 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.913433e-01 | 0.536 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.913433e-01 | 0.536 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.154657e-01 | 0.381 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.154657e-01 | 0.381 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.154657e-01 | 0.381 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.154657e-01 | 0.381 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.154657e-01 | 0.381 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.914300e-01 | 0.718 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.914300e-01 | 0.718 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.474829e-01 | 0.606 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.474829e-01 | 0.606 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.474829e-01 | 0.606 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.474829e-01 | 0.606 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.474829e-01 | 0.606 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.474829e-01 | 0.606 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.474829e-01 | 0.606 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.474829e-01 | 0.606 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.133177e-01 | 0.671 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.305479e-01 | 0.481 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.305479e-01 | 0.481 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.305479e-01 | 0.481 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.305479e-01 | 0.481 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.305479e-01 | 0.481 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.856670e-01 | 0.731 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.627190e-01 | 0.789 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.627190e-01 | 0.789 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.761414e-01 | 0.559 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.358523e-01 | 0.627 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.358523e-01 | 0.627 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.589155e-01 | 0.587 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.589155e-01 | 0.587 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.050997e-01 | 0.516 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.691196e-01 | 0.433 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.691196e-01 | 0.433 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.691196e-01 | 0.433 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.691196e-01 | 0.433 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.691196e-01 | 0.433 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.749952e-01 | 0.323 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.749952e-01 | 0.323 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.749952e-01 | 0.323 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.749952e-01 | 0.323 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.749952e-01 | 0.323 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.104398e-01 | 0.677 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.823916e-01 | 0.549 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.823916e-01 | 0.549 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.823916e-01 | 0.549 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.823916e-01 | 0.549 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.823916e-01 | 0.549 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.341701e-01 | 0.476 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.341701e-01 | 0.476 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.341701e-01 | 0.476 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.341701e-01 | 0.476 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.446543e-01 | 0.611 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.067810e-01 | 0.391 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.826571e-01 | 0.549 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.826571e-01 | 0.549 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.012737e-01 | 0.696 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.012737e-01 | 0.696 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.631825e-01 | 0.440 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 3.631825e-01 | 0.440 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.631825e-01 | 0.440 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.444339e-01 | 0.612 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.681042e-01 | 0.774 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.284475e-01 | 0.641 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.301395e-01 | 0.481 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.140284e-01 | 0.670 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.031969e-01 | 0.518 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.031969e-01 | 0.518 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.803349e-01 | 0.552 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.270920e-01 | 0.644 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.880072e-01 | 0.726 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.239510e-01 | 0.490 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.919846e-01 | 0.407 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.919846e-01 | 0.407 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.433176e-01 | 0.353 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.433176e-01 | 0.353 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.433176e-01 | 0.353 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.433176e-01 | 0.353 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.433176e-01 | 0.353 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.725039e-01 | 0.565 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.782617e-01 | 0.422 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.272703e-01 | 0.643 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.272703e-01 | 0.643 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.820069e-01 | 0.550 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.204418e-01 | 0.376 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.204418e-01 | 0.376 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.658309e-01 | 0.437 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.488275e-01 | 0.604 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.107440e-01 | 0.508 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.343903e-01 | 0.476 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.733357e-01 | 0.428 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.612422e-01 | 0.442 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.612422e-01 | 0.442 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.260214e-01 | 0.371 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.260214e-01 | 0.371 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.957554e-01 | 0.403 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.286375e-01 | 0.368 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.758673e-01 | 0.323 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.758673e-01 | 0.323 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.493407e-01 | 0.347 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.727906e-01 | 0.325 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.727906e-01 | 0.325 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.698427e-01 | 0.328 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.298578e-01 | 0.367 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.644971e-01 | 0.333 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.770850e-01 | 0.752 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.298382e-01 | 0.367 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.444339e-01 | 0.612 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.787953e-01 | 0.422 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.544966e-01 | 0.450 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.703085e-01 | 0.769 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.143632e-01 | 0.669 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.495646e-01 | 0.347 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.474829e-01 | 0.606 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.444339e-01 | 0.612 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.919846e-01 | 0.407 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.922012e-01 | 0.406 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.133177e-01 | 0.671 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.006245e-01 | 0.698 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.357294e-01 | 0.474 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.890924e-01 | 0.539 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.305479e-01 | 0.481 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.761414e-01 | 0.559 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.006245e-01 | 0.698 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.623363e-01 | 0.581 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.358523e-01 | 0.627 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.446543e-01 | 0.611 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.325573e-01 | 0.364 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.150749e-01 | 0.667 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.597686e-01 | 0.337 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.810212e-01 | 0.419 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.654358e-01 | 0.781 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.691196e-01 | 0.433 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.691196e-01 | 0.433 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.067810e-01 | 0.391 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.287446e-01 | 0.641 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.681042e-01 | 0.774 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.542023e-01 | 0.451 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.433176e-01 | 0.353 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.698427e-01 | 0.328 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.479691e-01 | 0.349 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.907645e-01 | 0.408 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.124763e-01 | 0.385 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.495646e-01 | 0.347 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.493407e-01 | 0.347 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.050997e-01 | 0.516 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.301395e-01 | 0.481 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.542023e-01 | 0.451 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.260214e-01 | 0.371 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.136739e-01 | 0.670 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.914300e-01 | 0.718 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.691196e-01 | 0.433 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.749952e-01 | 0.323 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.839747e-01 | 0.735 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.170810e-01 | 0.499 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.253507e-01 | 0.488 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.922012e-01 | 0.406 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.919021e-01 | 0.717 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.985997e-01 | 0.525 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.583806e-01 | 0.588 | 1 | 1 |
| Glycogen synthesis | R-HSA-3322077 | 2.823916e-01 | 0.549 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.761201e-01 | 0.322 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.761201e-01 | 0.322 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.654358e-01 | 0.781 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.493407e-01 | 0.347 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.727906e-01 | 0.325 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.896775e-01 | 0.538 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.644620e-01 | 0.578 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.239510e-01 | 0.490 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.448509e-01 | 0.462 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.698427e-01 | 0.328 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.985997e-01 | 0.525 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.617321e-01 | 0.791 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.378512e-01 | 0.624 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.698402e-01 | 0.432 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.125311e-01 | 0.673 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.940057e-01 | 0.712 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.691196e-01 | 0.433 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.061687e-01 | 0.514 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.919846e-01 | 0.407 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.932956e-01 | 0.533 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.448509e-01 | 0.462 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.679236e-01 | 0.572 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.868280e-01 | 0.412 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.485283e-01 | 0.348 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.698427e-01 | 0.328 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.023835e-01 | 0.395 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.597686e-01 | 0.337 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.174705e-01 | 0.498 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.782617e-01 | 0.422 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.698402e-01 | 0.432 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.972565e-01 | 0.401 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.914300e-01 | 0.718 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.031920e-01 | 0.518 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.151263e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.421079e-01 | 0.616 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.322483e-01 | 0.479 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.100568e-01 | 0.509 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.154657e-01 | 0.381 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.154657e-01 | 0.381 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.341701e-01 | 0.476 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.624017e-01 | 0.581 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.542023e-01 | 0.451 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.766436e-01 | 0.753 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.077824e-01 | 0.390 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.039766e-01 | 0.690 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.922012e-01 | 0.406 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.544966e-01 | 0.450 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.440669e-01 | 0.463 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.848152e-01 | 0.415 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.589155e-01 | 0.587 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.446543e-01 | 0.611 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.446543e-01 | 0.611 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.922012e-01 | 0.406 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.922012e-01 | 0.406 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.589155e-01 | 0.587 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.803349e-01 | 0.552 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.473850e-01 | 0.459 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.784834e-01 | 0.422 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.481550e-01 | 0.458 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.341701e-01 | 0.476 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.542023e-01 | 0.451 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.436402e-01 | 0.353 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.260214e-01 | 0.371 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.780837e-01 | 0.749 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.205322e-01 | 0.376 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.617321e-01 | 0.791 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.922012e-01 | 0.406 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.597119e-01 | 0.797 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.932617e-01 | 0.714 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.754061e-01 | 0.560 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.491907e-01 | 0.457 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.491907e-01 | 0.457 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.491907e-01 | 0.457 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.654358e-01 | 0.781 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.154657e-01 | 0.381 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.154657e-01 | 0.381 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.474829e-01 | 0.606 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.305479e-01 | 0.481 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.856670e-01 | 0.731 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.761414e-01 | 0.559 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.230319e-01 | 0.652 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.446543e-01 | 0.611 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.067810e-01 | 0.391 | 1 | 1 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.892929e-01 | 0.723 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.803349e-01 | 0.552 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.239510e-01 | 0.490 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.919846e-01 | 0.407 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.433176e-01 | 0.353 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.186689e-01 | 0.497 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.544966e-01 | 0.450 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.484365e-01 | 0.348 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.758673e-01 | 0.323 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.302587e-01 | 0.366 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.808014e-01 | 0.419 | 1 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.446543e-01 | 0.611 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.089812e-01 | 0.510 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.707372e-01 | 0.567 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.604468e-01 | 0.584 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.357294e-01 | 0.474 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.919846e-01 | 0.407 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.653277e-01 | 0.576 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.616096e-01 | 0.792 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.094364e-01 | 0.509 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.077824e-01 | 0.390 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.220223e-01 | 0.492 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.193295e-01 | 0.659 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.341701e-01 | 0.476 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.341701e-01 | 0.476 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.698427e-01 | 0.328 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.664559e-01 | 0.574 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.485283e-01 | 0.348 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.782617e-01 | 0.422 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.127143e-01 | 0.505 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.227673e-01 | 0.652 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.620663e-01 | 0.335 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.425024e-01 | 0.615 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.273389e-01 | 0.643 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.404436e-01 | 0.619 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.125311e-01 | 0.673 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.913433e-01 | 0.536 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 3.782617e-01 | 0.422 | 1 | 1 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.727906e-01 | 0.325 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.621249e-01 | 0.441 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.298578e-01 | 0.367 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.957746e-01 | 0.708 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.542023e-01 | 0.451 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.067810e-01 | 0.391 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.020910e-01 | 0.396 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.269929e-01 | 0.485 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.620663e-01 | 0.335 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.572782e-01 | 0.340 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.146491e-01 | 0.382 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.940057e-01 | 0.712 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.782617e-01 | 0.422 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.342795e-01 | 0.630 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.055020e-01 | 0.687 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.871317e-01 | 0.542 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.871317e-01 | 0.542 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.871317e-01 | 0.542 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.125311e-01 | 0.673 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.691196e-01 | 0.433 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.691196e-01 | 0.433 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.749952e-01 | 0.323 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.067810e-01 | 0.391 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.287446e-01 | 0.641 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.826571e-01 | 0.549 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.631825e-01 | 0.440 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.892929e-01 | 0.723 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.892929e-01 | 0.723 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.239510e-01 | 0.490 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.919846e-01 | 0.407 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.433176e-01 | 0.353 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.433176e-01 | 0.353 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.236555e-01 | 0.490 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.727906e-01 | 0.325 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.542023e-01 | 0.451 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.104398e-01 | 0.677 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.681756e-01 | 0.572 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.585711e-01 | 0.445 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.067810e-01 | 0.391 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.922012e-01 | 0.406 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.682509e-01 | 0.434 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.284475e-01 | 0.641 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.022923e-01 | 0.395 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.518578e-01 | 0.599 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.302587e-01 | 0.366 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.957554e-01 | 0.403 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.367677e-01 | 0.473 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.520404e-01 | 0.453 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.367677e-01 | 0.473 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.714025e-01 | 0.430 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.287446e-01 | 0.641 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.867789e-01 | 0.413 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.615706e-01 | 0.336 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.022287e-01 | 0.396 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.130247e-01 | 0.384 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.301395e-01 | 0.481 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.957554e-01 | 0.403 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.754061e-01 | 0.560 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.040628e-01 | 0.690 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.691196e-01 | 0.433 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.749952e-01 | 0.323 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.067810e-01 | 0.391 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 2.575458e-01 | 0.589 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.413651e-01 | 0.355 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.826571e-01 | 0.549 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.844972e-01 | 0.734 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.826571e-01 | 0.549 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 3.050997e-01 | 0.516 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.892929e-01 | 0.723 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.542023e-01 | 0.451 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.474829e-01 | 0.606 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.597686e-01 | 0.337 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.484365e-01 | 0.348 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.125311e-01 | 0.673 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.913433e-01 | 0.536 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.761414e-01 | 0.559 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.691196e-01 | 0.433 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.341701e-01 | 0.476 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.631121e-01 | 0.788 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.204418e-01 | 0.376 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.439683e-01 | 0.613 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.803349e-01 | 0.552 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.270920e-01 | 0.644 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.823916e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.779215e-01 | 0.750 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.911496e-01 | 0.536 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.782617e-01 | 0.422 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.716529e-01 | 0.326 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.758673e-01 | 0.323 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.940057e-01 | 0.712 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.766052e-01 | 0.322 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.778670e-01 | 0.321 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.778670e-01 | 0.321 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.785681e-01 | 0.320 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.785681e-01 | 0.320 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.785681e-01 | 0.320 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.785681e-01 | 0.320 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.785681e-01 | 0.320 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.785681e-01 | 0.320 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.785681e-01 | 0.320 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.785681e-01 | 0.320 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.790631e-01 | 0.320 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.805436e-01 | 0.318 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.814435e-01 | 0.317 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.814435e-01 | 0.317 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.814435e-01 | 0.317 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.814435e-01 | 0.317 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.851120e-01 | 0.314 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.854640e-01 | 0.314 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.854640e-01 | 0.314 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.856486e-01 | 0.314 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.876879e-01 | 0.312 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.897293e-01 | 0.310 | 1 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.900379e-01 | 0.310 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.900983e-01 | 0.310 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.900983e-01 | 0.310 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.900983e-01 | 0.310 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.935522e-01 | 0.307 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.956385e-01 | 0.305 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.956385e-01 | 0.305 | 1 | 1 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.956385e-01 | 0.305 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.956385e-01 | 0.305 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.956385e-01 | 0.305 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.011467e-01 | 0.300 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.026482e-01 | 0.299 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.026482e-01 | 0.299 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.026482e-01 | 0.299 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.026482e-01 | 0.299 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.026482e-01 | 0.299 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.036416e-01 | 0.298 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.036416e-01 | 0.298 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.036416e-01 | 0.298 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.036416e-01 | 0.298 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.036416e-01 | 0.298 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.043851e-01 | 0.297 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.049541e-01 | 0.297 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.084583e-01 | 0.294 | 1 | 1 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.100661e-01 | 0.292 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.124156e-01 | 0.290 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.124156e-01 | 0.290 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.124156e-01 | 0.290 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.124156e-01 | 0.290 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.124156e-01 | 0.290 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.124156e-01 | 0.290 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.124156e-01 | 0.290 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.124156e-01 | 0.290 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.124156e-01 | 0.290 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.124156e-01 | 0.290 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.124156e-01 | 0.290 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.124156e-01 | 0.290 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.124156e-01 | 0.290 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.124156e-01 | 0.290 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.124156e-01 | 0.290 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.124156e-01 | 0.290 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.125244e-01 | 0.290 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.148567e-01 | 0.288 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.151717e-01 | 0.288 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.180541e-01 | 0.286 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.180541e-01 | 0.286 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.180541e-01 | 0.286 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.180541e-01 | 0.286 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.180541e-01 | 0.286 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.180541e-01 | 0.286 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 5.215844e-01 | 0.283 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.215844e-01 | 0.283 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.215844e-01 | 0.283 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.228109e-01 | 0.282 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.244925e-01 | 0.280 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.284653e-01 | 0.277 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.284653e-01 | 0.277 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.284653e-01 | 0.277 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.284653e-01 | 0.277 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.284653e-01 | 0.277 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.284653e-01 | 0.277 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.284653e-01 | 0.277 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.284653e-01 | 0.277 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.284653e-01 | 0.277 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.284653e-01 | 0.277 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.284653e-01 | 0.277 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.287072e-01 | 0.277 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.287072e-01 | 0.277 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.287072e-01 | 0.277 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.287072e-01 | 0.277 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.287072e-01 | 0.277 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.287072e-01 | 0.277 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.292594e-01 | 0.276 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.312749e-01 | 0.275 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.312749e-01 | 0.275 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.312749e-01 | 0.275 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.329867e-01 | 0.273 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.329867e-01 | 0.273 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.364192e-01 | 0.270 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.392643e-01 | 0.268 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.399902e-01 | 0.268 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.399902e-01 | 0.268 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.399902e-01 | 0.268 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.406164e-01 | 0.267 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.447802e-01 | 0.264 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.447802e-01 | 0.264 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.447802e-01 | 0.264 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.447802e-01 | 0.264 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.482254e-01 | 0.261 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.489914e-01 | 0.260 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.489914e-01 | 0.260 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.489914e-01 | 0.260 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.489914e-01 | 0.260 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.539725e-01 | 0.257 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.539858e-01 | 0.257 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.539858e-01 | 0.257 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.539858e-01 | 0.257 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.539858e-01 | 0.257 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.594315e-01 | 0.252 | 1 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.614058e-01 | 0.251 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.614058e-01 | 0.251 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.634256e-01 | 0.249 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.654998e-01 | 0.248 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.654998e-01 | 0.248 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.678850e-01 | 0.246 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.737356e-01 | 0.241 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.751684e-01 | 0.240 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.756129e-01 | 0.240 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.756129e-01 | 0.240 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.756129e-01 | 0.240 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.756129e-01 | 0.240 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.756129e-01 | 0.240 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.756129e-01 | 0.240 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.764924e-01 | 0.239 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.764924e-01 | 0.239 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.764924e-01 | 0.239 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.764924e-01 | 0.239 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.764924e-01 | 0.239 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.764924e-01 | 0.239 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.764924e-01 | 0.239 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.764924e-01 | 0.239 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.764924e-01 | 0.239 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 5.764924e-01 | 0.239 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.764924e-01 | 0.239 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.764924e-01 | 0.239 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.764924e-01 | 0.239 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.764924e-01 | 0.239 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.764924e-01 | 0.239 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.764924e-01 | 0.239 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.764924e-01 | 0.239 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.764924e-01 | 0.239 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.764924e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.764924e-01 | 0.239 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.784372e-01 | 0.238 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.784372e-01 | 0.238 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.803937e-01 | 0.236 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.822660e-01 | 0.235 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.842410e-01 | 0.233 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.863627e-01 | 0.232 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.863627e-01 | 0.232 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.975582e-01 | 0.224 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.984964e-01 | 0.223 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.984964e-01 | 0.223 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.020260e-01 | 0.220 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.020260e-01 | 0.220 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.020260e-01 | 0.220 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.025419e-01 | 0.220 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.025419e-01 | 0.220 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.025419e-01 | 0.220 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.025419e-01 | 0.220 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.044015e-01 | 0.219 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.048901e-01 | 0.218 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.048901e-01 | 0.218 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.048901e-01 | 0.218 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.048901e-01 | 0.218 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.048901e-01 | 0.218 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.048901e-01 | 0.218 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.048901e-01 | 0.218 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.048901e-01 | 0.218 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.048901e-01 | 0.218 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.048901e-01 | 0.218 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.068797e-01 | 0.217 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.123462e-01 | 0.213 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.125862e-01 | 0.213 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.125862e-01 | 0.213 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.196304e-01 | 0.208 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.196304e-01 | 0.208 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.196304e-01 | 0.208 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.196304e-01 | 0.208 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.196304e-01 | 0.208 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.196304e-01 | 0.208 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 6.196304e-01 | 0.208 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.196304e-01 | 0.208 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.196304e-01 | 0.208 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.196304e-01 | 0.208 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.222097e-01 | 0.206 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.222097e-01 | 0.206 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 6.222097e-01 | 0.206 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.222097e-01 | 0.206 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.229093e-01 | 0.206 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.244782e-01 | 0.204 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.247126e-01 | 0.204 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.247262e-01 | 0.204 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.247262e-01 | 0.204 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.309088e-01 | 0.200 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.309088e-01 | 0.200 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.326086e-01 | 0.199 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.326086e-01 | 0.199 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.326086e-01 | 0.199 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.326086e-01 | 0.199 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.326086e-01 | 0.199 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.326086e-01 | 0.199 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.326086e-01 | 0.199 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.326086e-01 | 0.199 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.326086e-01 | 0.199 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.390873e-01 | 0.194 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.390873e-01 | 0.194 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.390873e-01 | 0.194 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.399885e-01 | 0.194 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.412510e-01 | 0.193 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.412510e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.412510e-01 | 0.193 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.412510e-01 | 0.193 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.412510e-01 | 0.193 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.465212e-01 | 0.189 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.465212e-01 | 0.189 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.465212e-01 | 0.189 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.465212e-01 | 0.189 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.465212e-01 | 0.189 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.465212e-01 | 0.189 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.465212e-01 | 0.189 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.492136e-01 | 0.188 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.531506e-01 | 0.185 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.539161e-01 | 0.184 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.557045e-01 | 0.183 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.583767e-01 | 0.182 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.583767e-01 | 0.182 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.583767e-01 | 0.182 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.583767e-01 | 0.182 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.583767e-01 | 0.182 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.583767e-01 | 0.182 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.583767e-01 | 0.182 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.583767e-01 | 0.182 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.583767e-01 | 0.182 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.583767e-01 | 0.182 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.583767e-01 | 0.182 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.583767e-01 | 0.182 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.583767e-01 | 0.182 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.583767e-01 | 0.182 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.583767e-01 | 0.182 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.583767e-01 | 0.182 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.583767e-01 | 0.182 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.583767e-01 | 0.182 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.583767e-01 | 0.182 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.587823e-01 | 0.181 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.587823e-01 | 0.181 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.587823e-01 | 0.181 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.596518e-01 | 0.181 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.596518e-01 | 0.181 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.674018e-01 | 0.176 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.674018e-01 | 0.176 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.674018e-01 | 0.176 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.674018e-01 | 0.176 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.674018e-01 | 0.176 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.674018e-01 | 0.176 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.718228e-01 | 0.173 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.718228e-01 | 0.173 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.719770e-01 | 0.173 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.774026e-01 | 0.169 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.782204e-01 | 0.169 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.782204e-01 | 0.169 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.784683e-01 | 0.168 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.789615e-01 | 0.168 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.831082e-01 | 0.166 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.834382e-01 | 0.165 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.834382e-01 | 0.165 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.834382e-01 | 0.165 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.834382e-01 | 0.165 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.834382e-01 | 0.165 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.873661e-01 | 0.163 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.874346e-01 | 0.163 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.889676e-01 | 0.162 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.931781e-01 | 0.159 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.931781e-01 | 0.159 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.931781e-01 | 0.159 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.931781e-01 | 0.159 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.931781e-01 | 0.159 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.931781e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.931781e-01 | 0.159 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.931781e-01 | 0.159 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.931781e-01 | 0.159 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.931781e-01 | 0.159 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.931781e-01 | 0.159 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.931781e-01 | 0.159 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.931781e-01 | 0.159 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.931781e-01 | 0.159 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.944978e-01 | 0.158 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.014635e-01 | 0.154 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.016048e-01 | 0.154 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.034434e-01 | 0.153 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.063992e-01 | 0.151 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.064178e-01 | 0.151 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.064178e-01 | 0.151 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.064178e-01 | 0.151 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.066138e-01 | 0.151 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.066138e-01 | 0.151 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.066138e-01 | 0.151 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.066138e-01 | 0.151 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.066138e-01 | 0.151 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.066138e-01 | 0.151 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.066138e-01 | 0.151 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.066138e-01 | 0.151 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.087614e-01 | 0.149 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.087614e-01 | 0.149 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.087614e-01 | 0.149 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.239164e-01 | 0.140 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.244361e-01 | 0.140 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.244361e-01 | 0.140 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.244361e-01 | 0.140 | 1 | 1 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.244361e-01 | 0.140 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.244361e-01 | 0.140 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.244361e-01 | 0.140 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.244361e-01 | 0.140 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.244361e-01 | 0.140 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.244361e-01 | 0.140 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.244361e-01 | 0.140 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.244361e-01 | 0.140 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.244361e-01 | 0.140 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.244361e-01 | 0.140 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.244361e-01 | 0.140 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.244361e-01 | 0.140 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.245663e-01 | 0.140 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.245663e-01 | 0.140 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.245663e-01 | 0.140 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.266830e-01 | 0.139 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.267169e-01 | 0.139 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.267169e-01 | 0.139 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.283549e-01 | 0.138 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.283549e-01 | 0.138 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.283549e-01 | 0.138 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.308875e-01 | 0.136 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.339057e-01 | 0.134 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.378304e-01 | 0.132 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.418461e-01 | 0.130 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.418461e-01 | 0.130 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.418461e-01 | 0.130 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.421359e-01 | 0.130 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.425882e-01 | 0.129 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.479145e-01 | 0.126 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.479718e-01 | 0.126 | 1 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.487132e-01 | 0.126 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.487132e-01 | 0.126 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.487132e-01 | 0.126 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.487132e-01 | 0.126 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.487132e-01 | 0.126 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.487132e-01 | 0.126 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.487132e-01 | 0.126 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.487132e-01 | 0.126 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.487132e-01 | 0.126 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.488874e-01 | 0.126 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.491003e-01 | 0.125 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.525114e-01 | 0.123 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.525114e-01 | 0.123 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.525114e-01 | 0.123 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.525114e-01 | 0.123 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.525114e-01 | 0.123 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.525114e-01 | 0.123 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.525114e-01 | 0.123 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.525114e-01 | 0.123 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.525114e-01 | 0.123 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.525114e-01 | 0.123 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.525114e-01 | 0.123 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.525114e-01 | 0.123 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.525114e-01 | 0.123 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.534580e-01 | 0.123 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.563299e-01 | 0.121 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.563299e-01 | 0.121 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.563299e-01 | 0.121 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.577866e-01 | 0.120 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.582118e-01 | 0.120 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.607525e-01 | 0.119 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.609040e-01 | 0.119 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.609040e-01 | 0.119 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.645570e-01 | 0.117 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.645570e-01 | 0.117 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.677446e-01 | 0.115 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.677446e-01 | 0.115 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.677446e-01 | 0.115 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.677446e-01 | 0.115 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.677446e-01 | 0.115 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.677446e-01 | 0.115 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.677446e-01 | 0.115 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.701773e-01 | 0.113 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.701773e-01 | 0.113 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.701773e-01 | 0.113 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.701773e-01 | 0.113 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.701773e-01 | 0.113 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.703227e-01 | 0.113 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.737469e-01 | 0.111 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.755165e-01 | 0.110 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.777277e-01 | 0.109 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.777277e-01 | 0.109 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.777277e-01 | 0.109 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.777277e-01 | 0.109 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.777277e-01 | 0.109 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.777277e-01 | 0.109 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.777277e-01 | 0.109 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.777277e-01 | 0.109 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.777277e-01 | 0.109 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.777277e-01 | 0.109 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.777277e-01 | 0.109 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.806105e-01 | 0.108 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.833432e-01 | 0.106 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.855082e-01 | 0.105 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.855082e-01 | 0.105 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.855082e-01 | 0.105 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.855082e-01 | 0.105 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.884537e-01 | 0.103 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.003761e-01 | 0.097 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.003761e-01 | 0.097 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.003761e-01 | 0.097 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.003761e-01 | 0.097 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.003761e-01 | 0.097 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.003761e-01 | 0.097 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.003761e-01 | 0.097 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.020646e-01 | 0.096 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.022685e-01 | 0.096 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.023575e-01 | 0.096 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.023575e-01 | 0.096 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.079964e-01 | 0.093 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.080194e-01 | 0.093 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.080194e-01 | 0.093 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.080194e-01 | 0.093 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.080194e-01 | 0.093 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.094385e-01 | 0.092 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.141967e-01 | 0.089 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.144328e-01 | 0.089 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.144328e-01 | 0.089 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.154851e-01 | 0.089 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.154851e-01 | 0.089 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.154851e-01 | 0.089 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.155356e-01 | 0.089 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.155356e-01 | 0.089 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.159276e-01 | 0.088 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.174755e-01 | 0.088 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.174755e-01 | 0.088 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.174755e-01 | 0.088 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.174755e-01 | 0.088 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.174755e-01 | 0.088 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.174755e-01 | 0.088 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.175904e-01 | 0.087 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.194470e-01 | 0.086 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.194470e-01 | 0.086 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.194470e-01 | 0.086 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.194470e-01 | 0.086 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.207179e-01 | 0.086 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.207179e-01 | 0.086 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.207179e-01 | 0.086 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.207179e-01 | 0.086 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.207179e-01 | 0.086 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.207179e-01 | 0.086 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.207179e-01 | 0.086 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.207179e-01 | 0.086 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.232972e-01 | 0.084 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.296675e-01 | 0.081 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.303079e-01 | 0.081 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.303079e-01 | 0.081 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.318022e-01 | 0.080 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.318022e-01 | 0.080 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.318022e-01 | 0.080 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.318022e-01 | 0.080 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.318022e-01 | 0.080 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.318022e-01 | 0.080 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.318022e-01 | 0.080 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.368445e-01 | 0.077 | 1 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.389880e-01 | 0.076 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.389880e-01 | 0.076 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.389880e-01 | 0.076 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.389880e-01 | 0.076 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.389880e-01 | 0.076 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.389880e-01 | 0.076 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.389880e-01 | 0.076 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.395253e-01 | 0.076 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.395253e-01 | 0.076 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.395253e-01 | 0.076 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.395253e-01 | 0.076 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.405826e-01 | 0.075 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.405826e-01 | 0.075 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.406193e-01 | 0.075 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.413992e-01 | 0.075 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.423905e-01 | 0.074 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.445295e-01 | 0.073 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.445295e-01 | 0.073 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.445295e-01 | 0.073 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.451058e-01 | 0.073 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.451058e-01 | 0.073 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.451058e-01 | 0.073 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.451058e-01 | 0.073 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.451058e-01 | 0.073 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.451058e-01 | 0.073 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.451058e-01 | 0.073 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.451058e-01 | 0.073 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.497170e-01 | 0.071 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.504964e-01 | 0.070 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.504964e-01 | 0.070 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.533175e-01 | 0.069 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.533175e-01 | 0.069 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.553972e-01 | 0.068 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.553972e-01 | 0.068 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.553972e-01 | 0.068 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.553972e-01 | 0.068 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.574457e-01 | 0.067 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.574457e-01 | 0.067 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.574457e-01 | 0.067 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.574457e-01 | 0.067 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.608078e-01 | 0.065 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.608078e-01 | 0.065 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.612494e-01 | 0.065 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.630673e-01 | 0.064 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.688803e-01 | 0.061 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.688803e-01 | 0.061 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.688803e-01 | 0.061 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.688803e-01 | 0.061 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.688803e-01 | 0.061 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.688803e-01 | 0.061 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.688803e-01 | 0.061 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.701349e-01 | 0.060 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.701349e-01 | 0.060 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.701349e-01 | 0.060 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.701349e-01 | 0.060 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.701349e-01 | 0.060 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.701349e-01 | 0.060 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.701349e-01 | 0.060 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.701349e-01 | 0.060 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.701349e-01 | 0.060 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.701349e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.704893e-01 | 0.060 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.711645e-01 | 0.060 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.711645e-01 | 0.060 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.744514e-01 | 0.058 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.767329e-01 | 0.057 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.794659e-01 | 0.056 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.794659e-01 | 0.056 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.795705e-01 | 0.056 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.795705e-01 | 0.056 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.833714e-01 | 0.054 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.833714e-01 | 0.054 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.833714e-01 | 0.054 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.833714e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.833714e-01 | 0.054 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.833714e-01 | 0.054 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.833714e-01 | 0.054 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.841365e-01 | 0.053 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.841365e-01 | 0.053 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.841365e-01 | 0.053 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.844243e-01 | 0.053 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.845717e-01 | 0.053 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.864638e-01 | 0.052 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.880808e-01 | 0.052 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.880808e-01 | 0.052 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.919723e-01 | 0.050 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.952594e-01 | 0.048 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.952594e-01 | 0.048 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.952594e-01 | 0.048 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.952594e-01 | 0.048 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.952594e-01 | 0.048 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.952594e-01 | 0.048 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.960489e-01 | 0.048 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.983046e-01 | 0.047 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.983046e-01 | 0.047 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.983046e-01 | 0.047 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.985088e-01 | 0.046 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.989165e-01 | 0.046 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.031821e-01 | 0.044 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.035029e-01 | 0.044 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.035029e-01 | 0.044 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.035029e-01 | 0.044 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.035029e-01 | 0.044 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.035029e-01 | 0.044 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.035029e-01 | 0.044 | 0 | 0 |
| Translation | R-HSA-72766 | 9.038771e-01 | 0.044 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.055258e-01 | 0.043 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.057206e-01 | 0.043 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.059364e-01 | 0.043 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.059364e-01 | 0.043 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.059364e-01 | 0.043 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.059364e-01 | 0.043 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.059364e-01 | 0.043 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.066594e-01 | 0.043 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.066594e-01 | 0.043 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.095656e-01 | 0.041 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.123634e-01 | 0.040 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.143683e-01 | 0.039 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.143683e-01 | 0.039 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.155255e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.155255e-01 | 0.038 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.155255e-01 | 0.038 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.155255e-01 | 0.038 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.155255e-01 | 0.038 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.155255e-01 | 0.038 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.210660e-01 | 0.036 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.214762e-01 | 0.036 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.214762e-01 | 0.036 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.214762e-01 | 0.036 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.214762e-01 | 0.036 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.218314e-01 | 0.035 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.221608e-01 | 0.035 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.221608e-01 | 0.035 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.230509e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.241375e-01 | 0.034 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.241375e-01 | 0.034 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.241375e-01 | 0.034 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.241375e-01 | 0.034 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.241375e-01 | 0.034 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.241375e-01 | 0.034 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.241375e-01 | 0.034 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.241375e-01 | 0.034 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.241375e-01 | 0.034 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.241375e-01 | 0.034 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.247800e-01 | 0.034 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.253419e-01 | 0.034 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.280254e-01 | 0.032 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.280254e-01 | 0.032 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.286148e-01 | 0.032 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.314691e-01 | 0.031 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.318721e-01 | 0.031 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.318721e-01 | 0.031 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.330462e-01 | 0.030 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.339927e-01 | 0.030 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.340559e-01 | 0.030 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.340559e-01 | 0.030 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.340559e-01 | 0.030 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.375899e-01 | 0.028 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.375899e-01 | 0.028 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.388185e-01 | 0.027 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.388185e-01 | 0.027 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.388185e-01 | 0.027 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.388185e-01 | 0.027 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.389082e-01 | 0.027 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.389082e-01 | 0.027 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.413106e-01 | 0.026 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.424359e-01 | 0.026 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.424708e-01 | 0.026 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.432859e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.447093e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.447093e-01 | 0.025 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.447093e-01 | 0.025 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.447093e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.450570e-01 | 0.025 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.450570e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.450570e-01 | 0.025 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.473597e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.494007e-01 | 0.023 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.494007e-01 | 0.023 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.506597e-01 | 0.022 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.506597e-01 | 0.022 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.506597e-01 | 0.022 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.506597e-01 | 0.022 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.506597e-01 | 0.022 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.507577e-01 | 0.022 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.516930e-01 | 0.022 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.528474e-01 | 0.021 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.537106e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.537106e-01 | 0.021 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.537662e-01 | 0.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.547837e-01 | 0.020 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.553672e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.553672e-01 | 0.020 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.556913e-01 | 0.020 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.556913e-01 | 0.020 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.587784e-01 | 0.018 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.594337e-01 | 0.018 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.594983e-01 | 0.018 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.602101e-01 | 0.018 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.602101e-01 | 0.018 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.602101e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.602101e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.618206e-01 | 0.017 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.619438e-01 | 0.017 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.626090e-01 | 0.017 | 1 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.642683e-01 | 0.016 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.642683e-01 | 0.016 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.642683e-01 | 0.016 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.646319e-01 | 0.016 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.648795e-01 | 0.016 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.648795e-01 | 0.016 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.650045e-01 | 0.015 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.662018e-01 | 0.015 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.664565e-01 | 0.015 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.674725e-01 | 0.014 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.676007e-01 | 0.014 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.676869e-01 | 0.014 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.679129e-01 | 0.014 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.679129e-01 | 0.014 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.679129e-01 | 0.014 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.679129e-01 | 0.014 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.692181e-01 | 0.014 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.698039e-01 | 0.013 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.698039e-01 | 0.013 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.701219e-01 | 0.013 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.711858e-01 | 0.013 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.711858e-01 | 0.013 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.711858e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.711858e-01 | 0.013 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.727212e-01 | 0.012 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.730521e-01 | 0.012 | 0 | 0 |
| Phosphate bond hydrolysis by NTPDase proteins | R-HSA-8850843 | 9.741251e-01 | 0.011 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.741251e-01 | 0.011 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.741251e-01 | 0.011 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.758793e-01 | 0.011 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.764206e-01 | 0.010 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.766168e-01 | 0.010 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.766168e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.767648e-01 | 0.010 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.767648e-01 | 0.010 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.775518e-01 | 0.010 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.776971e-01 | 0.010 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.780087e-01 | 0.010 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.789097e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.791352e-01 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.791352e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.804145e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.809068e-01 | 0.008 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.809068e-01 | 0.008 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.812640e-01 | 0.008 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.812640e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.813199e-01 | 0.008 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.821883e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.829661e-01 | 0.007 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.831757e-01 | 0.007 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.832121e-01 | 0.007 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.848924e-01 | 0.007 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.849456e-01 | 0.007 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.857086e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.858011e-01 | 0.006 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.859145e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.867172e-01 | 0.006 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.869466e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.869474e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.878185e-01 | 0.005 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.878185e-01 | 0.005 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.878185e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.879526e-01 | 0.005 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.880044e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.890617e-01 | 0.005 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.911266e-01 | 0.004 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.911806e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.911806e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.911806e-01 | 0.004 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.911806e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.911806e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.914895e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.916363e-01 | 0.004 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.919227e-01 | 0.004 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.920809e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.921673e-01 | 0.003 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.921673e-01 | 0.003 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.928893e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.928893e-01 | 0.003 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.933109e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.936152e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.936152e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.939144e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.939144e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.942670e-01 | 0.002 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.942670e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.948523e-01 | 0.002 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.948523e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.948523e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.949167e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.949167e-01 | 0.002 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.949658e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.949658e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.953779e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.954224e-01 | 0.002 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.958383e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.958499e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.962045e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.962415e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.962737e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.962737e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.962737e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.966039e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.971613e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.971613e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.971613e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.971854e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.975783e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.978256e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.978256e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.980433e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.980478e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.980683e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.980683e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.982462e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.982472e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.984810e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.985573e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.986342e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.987314e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.989200e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.990819e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.993374e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.993577e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.993866e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.994549e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995193e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.995684e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.995684e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.995940e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.996565e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996877e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.997197e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997454e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.997650e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.997666e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997741e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.997965e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997972e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998157e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998179e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998194e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998203e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.998489e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998533e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998659e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998683e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998683e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998761e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998974e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998985e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999145e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999145e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999150e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999311e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999311e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999425e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999583e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999583e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999742e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999800e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999813e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999824e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999835e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999841e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999899e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999901e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999903e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999904e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999926e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999939e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999939e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999948e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999954e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999968e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999970e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999971e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999978e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999986e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999988e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999988e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999992e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999993e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999996e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999997e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999998e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 1 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |